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Abstract 
 
 
Background: Mental health disorders and substance use contribute significantly to the burden of 
disease worldwide. These two conditions are relatively common among adolescents and young 
adults. Mental health disorders and substance use problems are closely linked, and both 
conditions can share similar biological, psychological, and social components. The co-occurrence 
of these two conditions presents complex challenges in their prevention, diagnosis, and treatment. 
If left untreated, these conditions may result in loss of productivity, poor educational outcomes, 
inefficient use of limited healthcare resources, and a higher prevalence of chronic diseases. 
 
Methods: A systematic review and meta-analysis was conducted to determine and quantify the 
association and directionality between mental health disorders and substance use among 
adolescents and/or young adults. Following this, the prevalence and association between mental 
health disorders and substance use among students attending Canadian post-secondary 
institutions was determined analyzing the American College Health Association - National 
College Health Assessment II - Canadian Reference Group survey, spring 2016. 
 
Results: Our systematic review and meta-analysis showed a significant association between 
depression and use of alcohol, cannabis, and tobacco. Significant associations were found 
between anxiety and use of alcohol, cannabis, and tobacco. A bidirectional relationship was 
observed with tobacco use at baseline leading to depression at follow-up and depression at 
baseline leading to tobacco use at follow-up. A unidirectional relationship was observed with 
cannabis use leading to depression. Our secondary data analysis showed that the odds of having 
depression were greater for current and former tobacco users. Current cannabis users with or 
without other mental health disorders were more likely to have depression. Also, former cannabis 
users without other mental health disorders were more likely to have depression. The odds of 
having anxiety were greater for current and former female alcohol users. 
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Conclusion: The findings and recommendations of this thesis can be used to assist healthcare 
professionals, health promoters, and policymakers when dealing with mental health disorders and 
substance use. By affecting change at the personal, interpersonal, and societal levels, we can 
assist adolescents and young adults to make better choices, seek supports as needed, and live 
healthier and well-adjusted lives.  
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Chapter 1: Introduction 
 
1.1 Mental health and mental health disorders 
 
Mental health refers to “a state of well-being in which every individual realizes his or her own 
potential, can cope with the normal stresses of life, can work productively and fruitfully, and is 
able to make a contribution to his or her community" (1). Mental health is important at every 
stage of a person’s life. It has a direct influence on children’s and adolescents’ development, 
young adults’ educational attainment, adults’ work-related productivity and shapes their adult 
personality and characteristics.  
 
Mental health disorders are defined as any alterations or abnormalities in thought, mood, 
perception, and/or behavior that can be attributed to distress and impair functioning (2). There are 
a number of mental health disorders with different presentations from mood and anxiety 
disorders to psychosis, dementia, intellectual disabilities, and developmental disorders. Mental 
health disorders are known to be the leading cause of ill-health and disability worldwide (3). It is 
reported that more than 450 million people across the globe suffer from mental health disorders 
(3). In Canada, about 9.1 million people are directly affected by a mental health disorder at some 
point in their lives, and many others are indirectly impacted by way of a family member, friend, 
or co-worker (4).  
 
Globally, mental health disorders are one of the leading causes of disease burden (3). Based on 
published data in 2016, mental health disorders account for 32.4% of years lived with disability 
compared to earlier estimate of 21.2% in 2013 (5). Additionally, a large number of individuals 
with mental health disorders remain undiagnosed and therefore, untreated, causing a major public 
health concern (6). It is reported that approximately two-thirds of patients who suffer from mental 
health disorders (35-50% in developed and 76-85% in developing countries) never seek 
professional help from a healthcare provider (6). This can be attributed to a variety of reasons 
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including 1) limited access to mental health treatment and social support services; 2) social 
stigma frequently associated with mental health disorders and the fear of discrimination which 
may discourage individuals from seeking and receiving the treatment they need; and 3) 
insufficient allocation of financial and human resources to help diagnose and treat individuals 
with mental health disorders.  
 
There are many factors that may contribute to poor mental health, including a) genetic and 
biological factors (such as chromosomal abnormalities and intelectual disability), b) individual 
characteristics and behaviors (such as poor emotional and social intelligence, low self-
confidence, poor communication skills, and medical illnesses and substance use), c) social 
circumstances (such as loneliness, family conflicts, exposure to violence or abuse, low income 
and poverty, difficulties or failure at school, and work related stress), and d) environmental 
factors (such as poor access to basic medical services, social supports and gender inequalities, 
and discrimination) (7). Poor mental health can be detrimental to people’s overall health and 
cause a substantial financial burden to our society.  
 
In Canada, the direct neuropsychiatric-related expenses on hospital stay, physician care, and 
medications are estimated to be $11 billion Canadian dollars (CAD) (8). The majority of 
expenses go toward mood/anxiety and alcohol/drug use disorders ($5 billion CAD) (8). 
According to the World Health Organization (WHO), the rate of work absenteeism as a result of 
mental health disorders represents a bigger problem than the one attributed to poor physical 
health (9). It is noteworthy to mention that mental and physical health are intricately linked. 
There is a bidirectional relationship between mental and physical health. For instance, mental 
illness can be a risk factor for the development of chronic physical ailments, and poor physical 
health can lead to the development of mental health disorders (10, 11).  
 
The two most common types of mental health disorders are mood and anxiety disorders (12). 
Globally, depression and anxiety are ranked as the first and sixth most common causes of years 
lived with disability (YLD) and significantly contribute to the overall poor quality of life (13).  
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1.1.1 Depressive disorders  
 
Depressive disorders are a group of disorders which include symptoms such as depressed mood 
or significantly diminished interest or pleasure, weight loss/gain, insomnia/hypersomnia, loss of 
energy, psychomotor agitation/retardation, feelings of guilt, loss of concentration, or suicidal 
ideation.  Severity may be coded separately and depends on various factors, depending on the 
specific disorder (14).  
 
Depression is the most common mental health disorder and the leading cause of disability in the 
world. Globally, more than 300 million people (4.4% of the world’s population) are estimated to 
suffer from depression (13). Depression is more common among females, single or divorced 
individuals, those who have family history of the disease, experienced traumatic life events, and 
those with alcohol/drug use disorders (15). According to WHO, the Americas (United States, 
Mexico, and Canada) is ranked as the geographical region with the fourth highest prevalence for 
depressive disorders (13). In 2015, it was estimated that 4.7% of Canadians suffered from 
depressive disorders, which accounted for 6.9% of the total YLD (13).  
 
1.1.2 Anxiety disorders  
 
Anxiety disorders are a group of disorders which include symptoms such as anxiety, excessive 
worrying and panic attacks, which are serious enough to interfere with a person’s functioning 
(14). Anxiety can be presented by symptoms such as muscle tension and vigilance in preparation 
for the forthcoming danger. The severity and duration of anxiety symptoms may vary between 
people and over time. There are many patients who suffer from anxiety symptoms even though 
they do not meet the criteria for the clinical diagnosis of anxiety disorders. Diagnosis of each 
anxiety disorder is only made after ruling out the physiological effects of substance or medication 
and in the absence of better explanation by another mental disorder. The age of onset for many 
anxiety disorders is in childhood with tendency to persist over time if left untreated. According to 
DSM-V the list of different anxiety disorders in developmental order are as follow: separation 
anxiety disorder, selective mutism, specific phobia, social anxiety disorder (social phobia), panic 
disorder, panic attack specifier, agoraphobia, generalized anxiety disorder (GAD), 
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substance/medication-induced anxiety disorders and anxiety disorder due to another medical 
condition (14). Social phobia usually develops during childhood or adolescence, panic disorder 
typically begins in late adolescence or early adulthood, and GAD can develop at any point in time 
but most commonly occurs between childhood and middle age (14). The proportion of people 
living with anxiety disorders in the world is 3.6% (approximately 264 million people) with the 
third highest rates reported in the region of the Americas (13). Specifically, in Canada, it is 
estimated that nearly 8.5 million people (20%) are at risk of suffering from an anxiety disorder in 
their lifetime. In fact, 1.6 million Canadians (4.9%) have been diagnosed with anxiety disorders, 
which represents 4% of the total YLD (13). 
 
1.2 Substance use and substance use disorders 
 
Substance use is a broad term defined as taking any substance which can eventually lead to 
alteration of the mental, physical, or emotional functioning of the body. There are different stages 
of substance use starting from initiation to occasional use and/or eventual addiction, which 
depend on the interplay of multiple risk factors. These factors can be broadly categorized into a) 
biological (such as age and sex), individual (such as personality and family history of substance 
use), b) social (education, employment, and peer pressure) and c) environmental (such as 
availability and access to substances) components (15). The diagnosis of substance use disorder 
is based on 11 criteria, including 1) harmful use of substances, 2) social problems related to use, 
3) interpersonal problems related to use, 4) spending a lot of time on substance use, 5) 
withdrawal symptoms, 6) the presence of a tolerance effect, 7) increasing amount or longer 
duration of substance use, 8) inability to cut down or quit using substances, 9) craving for 
substances, 10) physical/psychological dependance/problems related to use, and 11) foregoing 
major activities (such as home, work, or school activities) because of substance use. A patient 
must have at least two criteria within a 12-month period to be diagnosed with a substance use 
disorder (16).  
 
Substance use disorders account for a considerable share of the global burden of disease 
including disability and premature loss of life (17). Globally, it is estimated that 250 million 
people are substance users (18). In Canada, 2.1% of the population (2.8% males and 1.5% 
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females) suffer from substance use disorders (19). Alcohol, cannabis, and tobacco are reported to 
be the three most commonly used substances, worldwide. The global prevalence of alcohol use 
(heavy episodic drinking within the past 30 days), tobacco smoking (daily), and cannabis use 
(within the past year) were estimated at 16%, 15%, and 3.8%, respectively (18-20). In 2015, 
Canada reported a prevalence of alcohol use (heavy episodic drinking) at 15% (4.2 million 
people), tobacco smoking (daily) at 9% (2.8 million people), and cannabis use (within the past 
year) at 12% (3.6 million people) (21). Although tobacco and alcohol use are known to cause 
high rates of morbidity and mortality, not enough is known about the effects of cannabis use in 
our society. This issue becomes increasingly important when one considers an increasing trend in 
prevalence of cannabis use in Canada (22) and the fact that cannabis will be legal as of October 
17, 2018 (23).  
 
1.2.1 Tobacco 
 
Tobacco is one of the most commonly used addictive substances and the leading cause of 
premature mortality in Canada and the world (24, 25). Tobacco is highly addictive, and its long-
term use can lead to nicotine dependence and consequently, withdrawal symptoms for those who 
wish to quit (24, 25). It is widely known that tobacco use can cause a number of serious physical 
ailments, but there is less awareness about its detrimental effects on mental health. Early age of 
initiation is critically important with nearly 51.4% of tobacco users starting to smoke before the 
age of 18 years old (26). There are different factors associated with the early initiation of tobacco 
use, which include: a) environmental influences (such as social norms associated with peer and 
parental smoking behaviors and mass media advertising through the use of popular movies and 
music videos), b) biological (such as age and sex) and c) personality traits (such as rebelliousness 
and sensation-seeking) (27). Other risk factors that may be related to the initiation of tobacco use 
at a young age include: a) low socioeconomic status, b) availability, c) accessibility, and 
affordability of tobacco products, d) the presence of stress, e) low self-esteem, f) low level of 
academic achievement, and g) mental health disorders (27).  
 
  
6 
 
1.2.2 Alcohol 
 
Alcohol is known as a psychoactive substance which can cause dependency. Alcohol use can 
have a negative impact on an individual’s health, poses a risk to others and places a significant 
financial burden on our society (28). Globally, alcohol is known as the third leading risk factor 
for premature death and disability (29). Alcohol use is a risk factor for many chronic conditions 
(such as certain cancers, psychiatric disorders, cardiovascular and gastrointestinal diseases) (30). 
In 2012, alcohol use contributed to 3.3 million deaths (5.9%), globally (20). According to the 
Canadian center on substance abuse, most of the substance use related hospitalizations in Canada 
were due to alcohol use (31). Alcohol use is associated with an increased risk for alcohol use 
disorders, sexual assaults, and even serious death including those caused by car accidents (15, 
32). Driving under the influence of alcohol was recognized as the leading cause of criminal death 
in Canada in 2008 (33).    
 
1.2.3 Cannabis  
 
Cannabis is the most commonly abused illicit drug worldwide (34). The prevalence of cannabis 
use is estimated to be 2.5% (147 million people), globally (35). The most rapid growth in 
cannabis use is reported to take place in developed countries, including those in North America, 
Western Europe and Oceania (35). It is reported that the median age of cannabis initiation was 17 
years old in Canada (21). Cannabis use has both acute and chronic adverse health effects on its 
users. Acute effects of cannabis use may include cognitive impairment and interruption in 
psychomotor performance (which may increase the risk for a motor vehicle accident) (35). 
Chronic effects include respiratory damage (such as bronchitis, persistent lung inflammation, 
epithelial injury of the trachea) and exacerbation of certain mental health disorders (such as 
psychosis and schizophrenia) (35). There is growing concern that legalization of cannabis in 
many countries including Australia, Netherlands, parts of the United States and most recently 
Canada, may lead people to develop a false perception that it is safe to use and subsequenlty, 
underestimate the serious nature of the health hazards posed by cannabis (36).  
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1.3 Adolescents and young adults  
 
Adolescence (ages 10-17 years old) and young adulthood (ages 18-24 years old) are 
developmental periods markedly known for physical, mental, and emotional changes and growth. 
This age group (ages 10-24 years old) constitute about one fifth (18%) of Canada’s population in 
2017 (37). Attention to the health, particularly mental health, of this age group is often neglected 
as they are thought to be the healthiest subgroup within the general population. The mental health 
status of adolescents and young adults has a direct influence on their social contributions, 
productivity, education, employment, physical health, and overall well-being. Adolescents’ and 
young adults’ development and growth can be disrupted by a variety of physical or mental health 
illnesses. Mental health and substance use problems are two conditions that are more likely to be 
reported during adolescence and young adulthood (38).  
 
Worldwide, the prevalence of mental health disorders among adolescents and young adults is 10-
20% (39). Mental health disorders are the leading cause of disability among this vulnerable 
population, accounting for 45% of total morbidity (40). Depression and anxiety are the two most 
common mental health disorders affecting young people (12). In Canada, about 11% of 
individuals aged 15 to 24 years old have experienced at least one episode of major depressive 
disorder (41). In 2009, the prevalence of anxiety disorders was 4% among Canadians aged 12 to 
19 years old and 5.8% among those aged 20 to 29 years old (42).  
 
The diagnosis of mental health disorders among young people is challenging as it may be 
confused with the typical mood swings related to the transition from childhood to young 
adulthood. Prevention is better than treatment when it comes to the management of mental health 
disorders among adolescents and young adults. Management of mental health disorders should be 
in line with the need to address underlying causes such as school and work related stress, peer 
pressure, and identifying possible concomitant disorders.  
 
Substance use is another major health issue facing this age group (10-24 years old). Self-identity 
and a higher tendency for exploration and risk-taking are characteristics of young adults. These 
factors combined with social pressure from peers and the wider influence of social media may 
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encourage adolescents and young adults to use substances. Adolescents are at increased risk of 
transitioning from experimental substance use to substance use disorders as their brain and body 
are still in the developmental stage (43). Substance use may alter the mental, physical, or 
emotional function of the body, reduce self-control and increase risky behaviors and violence (44, 
45). It is reported that the likelihood of developing a substance use disorder among those who 
initiated use of an addictive substance by the age of 14 years old was greater than those who start 
after the age of 21 years old (46). In Canada, the prevalence of substance use disorders is nearly 
3.6% among Canadians aged 15-19 years old and 5.6% among those age 20-24 years old (19).  
 
1.3.1 Students 
  
Issues related to poor mental health and substance use are a growing public health concern among 
university aged students. In 2016, 14.7% of Canadian post-secondary students reported that they 
have been diagnosed or treated for depression and 18.4% for anxiety within the past 12-months. 
(47). School-related challenges such as coursework and examination stress, financial difficulties 
and separation from family and childhood friends may consider factors related to mental health 
problems for this age group. It is reported that number of students seeking mental health services 
and presenting with more severe psychological issues have risen significantly in Canadian post-
secondary campuses (48). A study conducted among Ontario’s college students showed that 
students with poor mental health had challenges (such as alertness/attention challenges and 
memory/executive function problems) with their academic performance (49). Another serious 
problem facing students is substance use. Evidence suggests that prevalence of alcohol, cannabis, 
and tobacco use is high among Canadian post-secondary students (47). Engaging in such 
behaviors may be related to the stress associated with the academic environment, competition 
with other students, peer influence, and the need for social acceptability and belonging. 
 
1.4 Relevance  
 
Substance use and mental health disorders are two conditions that significantly affect the mood, 
thinking, and behavior of an individual. There are reports of high prevalence of substance use and 
mental health disorders among adolescents and young adults in Canada (12, 21). According to a 
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study, people with mental health disorders were two times more likely to have a substance use 
problem compared to the general population and people with substance use problems were nearly 
three times more likely to have a mental health disorder (50). Dealing with substance use or 
mental health disorders is quite difficult, and it becomes even more challenging when there is a 
co-occurrence of both conditions among young people. Openly and proactively addressing 
adolescents’ and young adults’ mental health needs and substance use related problems can have 
a positive impact on an individuals’ academic, personal, and professional life, and that of their 
families, and communities. One of the hypotheses used to help explain the dual co-occurrence of 
substance use and mental health disorders is the self-medication hypothesis (51). It is postulated 
that people use a substance as a potential therapy to medicate the uncomfortable effects of mental 
health symptoms (51). For instance, a depressed person may use cannabis to relieve his/her 
symptoms of sadness and/or an anxious person may use alcohol to feel more relaxed in social 
settings. Given the high prevalence of mental health disorders and substance use, it is important 
that patients diagnosed with mental health disorder and/or a substance use be evaluated and if 
need be, treated for both conditions. 
 
The findings and key recommendations of this thesis can be used to assist healthcare 
professionals, health promoters, and policymakers when dealing with mental health disorders and 
substance use among adolescents and young adults. It can also provide them with critical insight 
when planning initiatives aimed at reducing the burden of depression and anxiety among 
adolescents and young adults with a focus on substance use. This will permit more effective and 
efficient use of their limited financial and human resources.  
 
1.5 Objectives 
 
1. To determine and quantify the association and directionality between mental health disorders 
and substance use among adolescents and/or young adults by conducting a systematic review 
and meta-analysis. 
2. To determine the prevalence and association between mental health disorders and substance 
use among students attending Canadian post-secondary institutions by analyzing the 
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American College Health Association - National College Health Assessment II (ACHA-
NCHA II) - Canadian Reference Group survey, spring 2016. 
 
1.6 Methods 
 
To address the first objective of our study a systematic review and meta-analysis was conducted. 
The research question was developed describing the Populations of interest (adolescents and 
young adults), Exposures (Substance use, such as alcohol, cannabis, and tobacco), Comparators 
(adolescents and young adults not using substances), and Outcomes (anxiety and/or depression) 
(PECO). The PECO statement was the foundation of the entire systematic review upon which the 
search strategy, inclusion/exclusion criteria, data extraction, and synthesis of results was based. 
Once the research question was defined, an appropriate protocol for the systematic review and 
meta-analysis was developed. The literature search used relevant databases and snowballing 
techniques. Dual independent title, abstract, and full-text screening of all eligible studies were 
conducted based on the inclusion/exclusion criteria. Data were extracted, the methodological 
quality of included studies was assessed, and results were summarized. Meta-analysis was used 
to quantify the pooled results from the included studies. Finally, publication bias and sub-group 
analysis was assessed (refer to chapter two).  
 
To address the second objective, multiple logistic regression was conducted. The ACHA-NCHA 
II - Canadian Reference Group survey, spring 2016 was the source of data for this study. Initial 
descriptive statistics were reported for the dependent (depression/anxiety) and independent 
(alcohol, cannabis, and tobacco) variables of interest. Unconditional analysis was conducted to 
estimate the relationship between the exposures of interest (substance use) and outcomes (mental 
health disorders). The independence of the exposure variables, accounting for potential 
confounders, and interaction terms were evaluated while building the models. Two separate 
multiple logistic regression models were built for predictive modeling (refer to chapter three). 
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1.7 Summary  
 
Mental health disorders and substance use contribute significantly to the burden of disease 
worldwide. The co-occurrence of these two conditions, especially among adolescents and young 
adults is a serious public health concern. Oftentimes, mental health disorders and substance use 
are underdiagnosed and remain unidentified. This is troubling due to the plethora of associated 
sequelae negatively impacting health, academic, personal, and professional life. This thesis aimed 
to comprehensively explore the association and directionality between mental health disorders 
and substance use in peer-reviewed studies and to identify the prevalence and association 
between these two conditions among Canadian post-secondary students. Findings of this thesis 
provide valuable insights and recommendations to healthcare professionals, policymakers and 
health promoters to better address challenges related to mental health disorders and substance 
use. 
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Chapter 2: Examining the association and directionality between mental health 
disorders and substance use among adolescents and young adults in the U.S. and 
Canada – A systematic review and meta-analysis 
 
2.1 Abstract  
 
Background: Mental health disorders and substance use contribute significantly to the burden of 
disease worldwide. Among adolescents and young adults, mental health disorders play an 
important role and place them at an increased risk for academic failure, criminal activity, and 
substance use. Substance use is a concern among this age group and negatively impacts their 
physical health and psychosocial development. The purpose of this systematic review was to 
examine the association and directionality between mental health disorders and substance use 
among adolescents and young adults in the U.S. and Canada. 
 
Methods: The following databases were used: Medline, PubMed, Embase, PsycINFO, and 
Cochrane Library. Dual title and abstracts were reviewed followed by full-text screening. Meta-
analysis used odds ratios as the pooled measure of effect. Where possible, causal relationships 
and the direction of causality was assessed using longitudinal studies.  
 
Results: After screening, 36 out of 3,656 studies were selected. Pooled results of the meta-
analysis showed a positive association between depression and use of alcohol (OR=1.50, 95% CI: 
1.24-1.83), cannabis (OR=1.29, 95% CI: 1.10-1.51), and tobacco (OR=1.65, 95% CI: 1.43-1.92).  
Significant associations were found between anxiety and use of alcohol (OR=1.54, 95% CI: 1.19-
2.00), cannabis (OR=1.36, 95% CI: 1.02-1.81), and tobacco (OR=2.21, 95% CI: 1.54-3.17). A 
bidirectional relationship was observed with tobacco use at baseline leading to depression at 
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follow-up (OR=1.87, CI=1.23-2.85) and depression at baseline leading to tobacco use at follow-
up (OR=1.22, CI=1.09-1.37). A unidirectional relationship was also observed with cannabis use 
leading to depression (OR=1.33, CI=1.19-1.49).  
 
Conclusion: This study offers insights into the association and directionality between mental 
health disorders and substance use among adolescents and young adults. The results of this study 
can help guide key stakeholders in making recommendations for interventions, policy and 
programming. Having up-to-date information about the relationships between mental health 
disorders and substance use is critical for professionals working with this vulnerable population 
to more effectively tailor services to comprehensively treat both of these conditions.  
 
Keywords: Depression, anxiety, alcohol, cannabis, tobacco, adolescents, young adults 
 
2.2 Introduction 
 
Mental health disorders and substance use are important problems and relatively common among 
adolescents and young adults (1). These two conditions are the leading cause of years lived with 
disability worldwide (2). People are more likely to initiate substance use during adolescence, a 
critical period in one’s life as they transition from childhood to adulthood (3). It is estimated that 
50% of all mental health disorders start by the age of 14 years old and 75% by the age of 25 years 
old (4). Mental health disorders and substance use problems are closely linked, and both 
conditions can share similar biological and environmental components (5, 6).  
 
Mental health disorders contribute significantly to the burden of disease (2). Globally, 
approximately one in five adolescents experience a mental health disorder each year (7). 
Depressive and anxiety disorders are quite prevalent among adolescents and young adults. In the 
U.S., 8.4% of adolescents were diagnosed with either anxiety or depression in their lifetime (8). 
In Canada, 5% of adolescents were diagnosed with an anxiety disorder and 6.3% with a mood 
disorder, mainly depression (9). Despite the magnitude of the problem posed by mental health 
disorders among adolescents and young adults in the U.S. and Canada, frequently they are 
undiagnosed and when diagnosed not treated properly (10).  
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Adolescents and young adults with mental health disorders are at an increased risk for many 
negative health and social outcomes including self-harm and suicide (11), poor academic 
performance (12), and involvement in risky behaviors and poor sexual health (13). Risk factors 
for mental health disorders include biological factors (such as genetic tendency, head trauma, and 
substance abuse), psychological factors (such as maladaptive personality traits, difficult 
temperament, and physical/sexual abuse), and social factors (such as family conflict, loss of a 
loved one, bullying, and academic failure) (14).  
 
Substance use among adolescents and young adults is a growing public health concern in 
developed countries such as the U.S. and Canada. Alcohol, cannabis, and tobacco are the 
substances most commonly used by adolescents and young adults. In Canada, the highest 
prevalence of alcohol (83%), cannabis (30%), and tobacco (18%) use was seen among young 
adults aged 20 to 24 years old followed by adolescents aged 15 to 19 years old (alcohol: 59%, 
cannabis: 21%, and tobacco: 10%) (15). Similar trends in the prevalence of substance use were 
seen in the U.S. (16). The magnitude of substance use among adolescents and young adults 
represents a major public health concern.  
 
Substance use among adolescents and young adults is associated with many negative health, 
social, and economic consequences. These vary from suicidal behaviors (17) to low academic 
performance and school dropout (18), employment problems later in life (19), and risky 
behaviors (20). Moreover, initiation of substance use in adolescence may be associated with the 
development of substance abuse and substance dependence later in life (21). Risk factors 
associated with substance use are found at the individual (such as age, sex, personality and family 
history of substance use), interpersonal (such as relationship with parents, siblings, and peer 
pressure), and environmental (such as social norms, availability and accessibility of substance) 
levels (22). 
 
Evidence suggests a complex interplay between substance use and vulnerability to mental health 
disorders. Several hypotheses have been postulated regarding the co-occurrence of these two 
conditions. The self-medication hypothesis suggests that coping with psychological pressures and 
stressors as they relate to maturation, untreated traumas, and underlying conditions may lead to 
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substance use and related risky behaviours (23). Moreover, environmental, genetic, and 
personality factors may predispose an individual to develop substance use problems and mental 
health disorders (22). However, it is less clearly established whether substance use and/or mental 
health disorders by themselves can lead to the development of either condition.  
 
Previous studies have been conducted examining the relationship between mental health 
disorders and substance use. Some studies have suggested that an association exists between 
depression and/or anxiety and alcohol, cannabis or tobacco use (24-29). However, findings in the 
literature have been inconsistent (30-35). Due to the high prevalence of mental health disorders 
and substance use among adolescents and young adults and the high potential of co-occurrence, 
further research in this important area is warranted. The purpose of this study was to examine the 
association and directionality between the three most common substances used (alcohol, 
cannabis, and tobacco) and two mental health disorders (depression and anxiety) among 
adolescents and young adults in the U.S. and Canada. 
 
 2.3 Methods 
 
2.3.1 Data sources  
 
We conducted an extensive systematic literature review on the following electronic databases: 
Medline, PubMed, Cochrane Library, Embase, and PsycINFO. Our searches consisted of two 
major categories and their corresponding MeSH terms and keywords: 1) Substance use 
behaviors: alcohol drinking, alcohol use, cannabis, marijuana smoking, marijuana use, smoking, 
tobacco smoking, tobacco use and 2) Mental health disorders: depression, depressive disorders, 
major depressive disorder, anxiety, anxiety disorders, and mood disorders. Snowball method 
(reference tracking) was also used to scan the reference lists of retrieved full-text articles and then 
to search manually for additional relevant literature.  
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2.3.2 Data extraction and analysis 
 
Two screeners (SE and NMKS), independently, reviewed the list of identified articles to assess 
eligibility for inclusion in our study. Any disagreements were resolved by a tiebreaker vote (YB). 
Extraction criteria included: year of publication, study design, sample size, target population, 
country where the study was conducted, measurement instrument used for substance use and 
mental health disorders, effect measure, covariates, and results. The effect measures examined 
the association between any of the following categories: 1) depression and alcohol use; 2) 
depression and cannabis use; 3) depression and tobacco use; 4) anxiety and alcohol use; 5) 
anxiety and cannabis use, and 6) anxiety and tobacco use. If a study discussed more than one of 
these categories, we extracted and analyzed all relevant effect measures separately.  
 
2.3.3 Definitions of mental health disorders and substance use  
 
The definitions and measurements of mental health disorders and substance use in different 
studies were heterogeneous. When multiple measures were used, we selected the most 
standardized and commonly used measure to maximize comparability between studies (Table 
2.1) (24-59). 
 
2.3.4 Quality assessment 
 
The modified Newcastle-Ottawa Scale (NOS) was used to assess the quality of both cross-
sectional and longitudinal study designs. This scale includes three components: 1) selection of 
study groups; 2) comparability of the groups; and the 3) ascertainment of the outcomes of interest 
(60). The quality of each study was determined by assigning them to one of three subgroups and 
designated as low, moderate, or high risk of bias.   
 
2.3.5 Meta-analysis 
 
Statistical analysis was completed using the Comprehensive Meta-Analysis software version 3 
(Biostat Inc., New Jersey, USA). For pooled mean effect size, random-effects models were used 
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because differences were expected in the methodology and the samples of selected studies (61). 
The primary outcome measure was Odds Ratio (OR). ORs and 95% confidence intervals (CI) 
were either extracted from the articles or calculated by the authors using the quantitative data 
provided in the studies. Six separate meta-analyses were conducted (Table 2.2). Q-statistics and 
I2 were used to examine the heterogeneity among studies. Publication bias was assessed by 
graphing funnel plots to visualize any possible asymmetries and Duval and Tweedie’s trim and 
fill test was conducted to adjust the results in case of publication bias (62). Sensitivity analysis 
was done using one-study removed analysis. Moreover, subgroup analysis was performed using 
moderator variables including point estimate (crude or adjusted), target population (adolescents 
and young adults), severity of mental health disorders (symptoms and disorders), and intensity of 
substance use behavior (definitions). 
 
2.4 Results 
 
2.4.1 Study selection and characteristics 
 
In total, 3,656 articles were identified by the initial search. After removing studies prior to the 
year 2000 and duplicates, 2,341articles remained. Title and abstract screening excluded 2,177 
articles, leaving 164 for full-text screening. After the full-text screening, 30 articles remained. Six 
additional articles were manually added by use of the snowball method. All 36 selected articles 
used either a cross-sectional (n=19) or longitudinal (n=17) study design. The summary of our 
study selection is shown in a PRISMA diagram (Figure 2.1). Study characteristics are presented 
in Table 2.2. The quality of studies was assessed using a modified Newcastle-Ottawa scale 
(NOS), which found 5 studies with a low, 27 with a moderate, and 4 with a high risk of bias. 
 
2.4.2 Synthesis of results 
 
The results of the meta-analysis found significant positive associations between depression and 
alcohol use (OR=1.50, 95% CI: 1.24-1.83), cannabis use (OR=1.29, 95% CI: 1.10-1.51) and 
tobacco use (OR=1.65, 95% CI: 1.43-1.92). Similarly, significant positive associations were 
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found between anxiety and alcohol use (OR=1.54, 95% CI: 1.19-2.00), cannabis use (OR=1.36, 
95% CI: 1.02-1.81) and tobacco use (OR=2.21, 95% CI: 1.54-3.17) (Table 2.3).  
 
2.4.3 Analysis of the directionality 
 
The directionality of the association between each relevant category was assessed by pooled 
analysis of the longitudinal studies. Results showed that there was a significant positive bi-
directional association between tobacco use at baseline leading to depression at follow-up 
(OR=1.87, CI=1.23-2.85) and depression at baseline leading to tobacco use at follow-up 
(OR=1.22, CI=1.09-1.37). Cannabis use at baseline was significantly associated with depression 
at follow-up (OR=1.33, CI=1.19-1.49) (Figure 2.2).  
 
2.4.4 Subgroup analysis 
 
Due to the heterogeneity detected upon pooled analysis, subgroup analysis was conducted to 
examine whether the differences within categories could be attributed to specific moderators (age 
group, measures of mental health disorder, and severity of substance use). Results of our 
subgroup analysis are summarized in Table 2.4. Results from the subgroup analysis by age group 
including adolescents (aged 10 to 18 years old) and young adults (aged 18 to 24 years old) found 
that the association between mental health disorders and substance use remained significant 
among adolescents but not among young adults. Subgroup analysis based on severity of mental 
health disorders showed a consistently higher point estimate for clinically diagnosed mental 
health disorder patients. Finally, subgroup analysis based on the intensity of substance use 
showed a recurring theme, whereby, as severity increased mental health disorders also increased 
(Table 2.4). 
 
2.4.5 Publication bias 
 
Funnel plots showed no evidence of publication bias in the included studies which examined the 
association between depression and alcohol use; depression and cannabis use; depression and 
tobacco use; anxiety and alcohol use; and anxiety and tobacco use. However, there was evidence 
of publication bias in the included studies which examined the association between anxiety and 
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cannabis use. Therefore, in these instances, a Duval and Tweedie’s trim and fill method was used 
to test and adjust for the publication bias in our meta-analysis.  
 
2.5 Discussion 
 
This study was conducted to examine the inter-association and directionality between the two 
most common mental health disorders (depression and anxiety) and three substances used 
(alcohol, cannabis, and tobacco) among adolescents and young adults in the U.S. and Canada. 
Our findings suggest that a significant association exists between depression and the use of 
alcohol, cannabis, and tobacco. Similarly, significant associations were found to exist between 
anxiety and the use of alcohol, cannabis, and tobacco. A bidirectional relationship was observed 
between depression and the use of tobacco. Additionally, we found evidence that cannabis use at 
baseline led to depression at follow-up. The results of our study were consistent with those 
reported in previous systematic reviews (63-65) and provide additional evidence in support of the 
inter-association between mental health disorders and substance use.  
 
Harmful alcohol use, which has been defined as heavy episodic or binge drinking is an important 
health issue among adolescents and young adults in the U.S. (66). The adolescent/young adult 
brain is still developing, and there is evidence to suggest that frequent use of alcohol at this age 
may lead to mental health disorders including depression (67, 68). Our results support these 
findings. We found that alcohol use was a significant predictor of higher levels of depression 
among adolescents and young adults. However, further research is needed in this area with more 
longitudinal studies, using longer follow-up periods.  
 
A systematic review conducted by Lev-Ran et al. found a positive association between cannabis 
use at baseline and the development of depression (69). Our results corroborate these findings 
and demonstrate that the overall pooled estimate for depression among heavy cannabis users was 
higher, compared to light users. Another systematic review by Number-Kedzior et al. found a 
significant positive association between cannabis use at baseline and anxiety at follow-up (65). In 
our study, it was not possible to infer whether such a causal relationship exists due to the lack of 
sufficient studies on this topic, which fit our inclusion criteria. Proposed mechanisms for the 
association between cannabis and depression could be due to biological effects from the 
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alteration in neurotransmitters such as serotonin in the brain (70) and its impact on developing 
depression and mediating psychosocial factors such as unemployment and educational failure 
(49). We observed that when adjusting for personal income and years of education, the 
association between cannabis use and depression was reduced (49). 
 
In our study, we found a stronger pooled estimate for tobacco use predicting depression, 
compared to depression predicting tobacco use. Moreover, a stronger pooled estimate was 
observed in those studies that used a clinical measure of depression rather than depressive 
symptoms. Our results are biologically plausible as there is evidence to suggest that dysregulation 
in the hypothalamic-pituitary-adrenal axis following smoking interferes with biological and 
psychological responses and leads to an imbalance in the levels of cortisol. Cortisol is also known 
as the stress hormone, and it affects mood, and therefore, its imbalance may lead to depression 
(71). The association between anxiety and tobacco use might be explained by the negative effect 
of tobacco use on different brain pathways such as neurotransmitter systems, inflammation and 
the immune system, oxidative and nitrosative stress pathways, neurotrophins and neurogenesis 
regulations, mitochondrial function, and epigenetic influences. Alteration in abovementioned 
pathways can also play a role in development of anxiety disorders (72).  
 
2.6 Strengths and limitations 
 
Our study has several strengths. There is a high level of congruence between our findings and 
those reported in the existing literature. However, this systematic review is unique because 1) it 
incorporates only studies originating in the U.S. and Canada, 2) it focuses on the adolescent and 
young adult population, and 3) it examines the associations and directionality between depression 
or anxiety and alcohol, cannabis, or tobacco use, separately.  
 
Despite its strengths, our study also has some limitations. We found that certain factors such as 
the study design (longitudinal vs. cross-sectional), the intensity of substance use (light vs. heavy), 
and the variation in clinical diagnosis (depressive and anxiety disorders vs. symptoms) affect the 
outcomes of our study. Participant’s age (adolescents vs. young adults) also influenced the inter-
association between substance use behaviors and mental health disorders. In our review, several 
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of our included studies used different instruments to measure depression and anxiety and a broad 
spectrum of measurements for substance use, making results difficult to compare due to their 
heterogeneity. When extracting data, we were unable to calculate the unadjusted odds ratio from 
all included studies. Different studies varied in the degree to which they controlled for potential 
confounders. Variation in the population sampled, length of follow-up in longitudinal studies, 
and different sample sizes also added to the variability. 
 
2.7 Conclusion  
 
This study offers significant insight into the association and directionality between substance use 
(alcohol, cannabis, and tobacco) and mental health disorders (depression and anxiety) among 
adolescents and young adults in the U.S. and Canada. The results of this study can help guide key 
stakeholders (school administrators, nurses, physicians, public health professionals, and 
policymakers) in making evidence-based recommendations for school-based interventions, 
policy, and programming. It is increasingly evident that adolescents and young adults with 
substance use issues may also suffer from co-occurring mental health disorders. However, they 
are frequently undiagnosed and consequently, they do not receive the specialized cross-treatment 
needed to address both conditions. To be most effective, school-based substance use and mental 
health programmes should consider integrating and expanding their services for patients with 
dual disorders. Further research is needed to help guide evidence-based treatment and initiatives 
for this vulnerable population. 
 
2.8 References 
 
1. Pearson C, Janz T, Ali J. Health at a glance: Mental and substance use disorders in Canada 
[Internet]. Ottawa: Statistics Canada; 2013 Sep [cited 2018 Sep 9]. Catalogue no.: 82-624-X. 
Available from: https://www150.statcan.gc.ca/n1/pub/82-624-x/2013001/article/11855-
eng.htm 
2. Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The Global Burden of Mental, 
Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease 
Study 2010. Forloni G, editor. PLoS One. 2015 Feb 6;10(2):e0116820.  
26 
 
3. Canadian Centre on Substance Abuse. Substance abuse in Canada: Youth in focus [Internet]. 
Ottawa: Canadian Centre on Substance Abuse; 2007 Sep [cited 2018 Sep 9]. Available from: 
http://www.ccsa.ca/Resource%20Library/ccsa-011521-2007-e.pdf 
4. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustün TB. Age of onset of 
mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007 Jul;20(4):359–64. 
5. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict 
Behav. 1998 Nov-Dec;23(6):717-34. 
6. Canadian Centre on Substance abuse. Substance abuse in Canada: Concurrent disorders 
[Internet]. Ottawa: Canadian Centre on Substance abuse; 2009 [cited 2018 Sep 9]. Available 
from: http://www.ccsa.ca/Resource%20Library/ccsa-011811-2010.pdf 
7. World Health Organization. Caring for children and adolescents with mental disorders: 
Setting WHO directions [Internet]. Geneva: World Health Organization; 2003 [cited 2018 
Sep 9]. Available from: http://www.who.int/mental_health/media/en/785.pdf 
8. Bitsko RH, Holbrook JR, Ghandour RM, Blumberg SJ, Visser SN, Perou R, et al. 
Epidemiology and Impact of Health Care Provider-Diagnosed Anxiety and Depression 
Among US Children. J Dev Behav Pediatr. 2018 Jun;39(5):395-403. 
9. Public Health Agency of Canada. Chapter 3: The Chief Public Health Officer's Report on the 
State of Public Health in Canada 2011 – The health and well-being of Canadian youth and 
young adults [Internet]. Ottawa: Government of Canada; 2011 [cited 2018Sep10]. Available 
from: https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-
officer-reports-state-public-health-canada/chief-public-health-officer-report-on-state-public-
health-canada-2011/chapter-3.html 
10. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. 
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health 
Organization World Mental Health Surveys. JAMA. 2004 Jun 2;291(21):2581-90. 
11. Holmes A, Silvestri R. Rates of Mental Illness and Associated Academic Impacts in 
Ontario’s College Students. Can J Sch Psychol. 2016 Mar 4;31(1):27-46. 
12. Gallagher M, Prinstein MJ, Simon V, Spirito A. Social anxiety symptoms and suicidal 
ideation in a clinical sample of early adolescents: examining loneliness and social support as 
longitudinal mediators. J Abnorm Child Psychol. 2014 Aug;42(6):871-83. 
13. Shrier LA, Harris S, Sternberg M, Beardslee WR. Associations of Depression, self-esteem, 
and substance use with sexual risk among adolescents. Prev Med. 2001 Sep; 33(3):179-89. 
14. Patel V, Flisher AJ, Hetrick S, McGorry P. Mental health of young people: a global public-
health challenge. Lancet. 2007 Apr 14;369(9569):1302-1313. 
15. Health Canada. Canadian Tobacco Alcohol and Drugs (CTADS): 2015 summary [Internet]. 
Ottawa: Government of Canada;2017 [cited 2018 Sep 9]. Available from: 
https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-
survey/2015-summary.html 
16. Banken JA. Drug abuse trends among youth in the United States. Ann N Y Acad Sci. 2004 
Oct;1025:465-71. 
17. Nock MK, Green JG, Hwang I, McLaughlin KA, Sampson NA, Zaslavsky AM, Kessler RC. 
Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results 
27 
 
from the National Comorbidity Survey Replication Adolescent Supplement. JAMA 
Psychiatry. 2013 Mar;70(3):300-10. 
18. Townsend L, Flisher AJ, King G. A systematic review of the relationship between high 
school dropout and substance use. Clin Child Fam Psychol Rev. 2007 Dec;10(4):295-317. 
19. Henkel D. Unemployment and substance use: a review of the literature (1990-2010). Curr 
Drug Abuse Rev. 2011 Mar;4(1):4-27. 
20. Ritchwood TD, Ford H, DeCoster J, Sutton M, Lochman JE. Risky Sexual Behavior and 
Substance Use among Adolescents: A Meta-analysis. Child Youth Serv Rev. 2015 
May;52:74-88. 
21. Jordan CJ, Andersen SL. Sensitive periods of substance abuse: Early risk for the transition to 
dependence. Dev Cogn Neurosci. 2017 Jun 1;25:29-44.  
22. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's Concise Textbook of Clinical Psychiatry. 
4th ed. Philadelphia: Wolters Kluwer; 2016. 
23. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration 
and recent applications. Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44.  
24. Chung SS, Joung KH. Risk factors for current smoking among American and South Korean 
adolescents, 2005-2011. J Nurs Scholarsh. 2014 Nov;46(6):408-15.  
25. Richter L, Pugh BS, Peters EA, Vaughan RD, Foster SE. Underage drinking: prevalence and 
correlates of risky drinking measures among youth aged 12-20. Am J Drug Alcohol Abuse. 
2016 Jul;42(4):385-94. 
26. Rasic D, Weerasinghe S, Asbridge M, Langille DB. Longitudinal associations of cannabis 
and illicit drug use with depression, suicidal ideation, and suicidal attempts among Nova 
Scotia high school students. Drug Alcohol Depend. 2013 Apr;129(1-2):49-53.  
27. Grunau GL, Ratner PA, Hossain S, Johnson JL. Depression and Anxiety as Possible 
Mediators of the Association Between Smoking and Attention Deficit Hyperactivity 
Disorder. Int J Ment Health Addict. 2010 Oct 1;8(4):595-607.  
28. Villarosa MC, Madson MB, Zeigler-Hill V, Noble JJ, Mohn RS. Social anxiety symptoms 
and drinking behaviors among college students: The mediating effects of drinking motives. 
Psychol Addict Behav. 2014 Sep;28(3):710-8. 
29. Buckner JD, Schmidt NB. Marijuana effect expectancies: relations to social anxiety and 
marijuana use problems. Addict Behav. 2008 Nov;33(11):1477-83. 
30. Hanna EZ, Yi HY, Dufour MC, Whitmore CC. The relationship of early-onset regular 
smoking to alcohol use, depression, illicit drug use, and other risky behaviors during early 
adolescence: results from the youth supplement to the third national health and nutrition 
examination survey. J Subst Abuse. 2001;13(3):265-82. 
31. Roberts SJ, Glod CA, Kim R, Hounchell J. Relationships between aggression, depression, 
and alcohol, tobacco: Implications for healthcare providers in student health. J Am Acad 
Nurse Pract. 2010 Jun 25;22(7):369-75. 
32. Kubik MY, Lytle LA, Birnbaum AS, Murray DM, Perry CL. Prevalence and correlates of 
depressive symptoms in young adolescents. Am J Health Behav. 2003 Sep-Oct;27(5):546-53. 
33. Goodwin RD, Lewinsohn PM, Seeley JR. Cigarette Smoking and Panic Attacks Among 
Young Adults in the Community: The Role of Parental Smoking and Anxiety Disorders. Biol 
Psychiatry. 2005 Nov 1;58(9):686-93.  
28 
 
34. Roberts RE, Roberts CR, Xing Y. Comorbidity of substance use disorders and other 
psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug 
Alcohol Depend. 2007 Apr;88 Suppl 1:S4-13. 
35. Low NC, Lee SS, Johnson JG, Williams JB, Harris ES. The association between anxiety and 
alcohol versus cannabis abuse disorders among adolescents in primary care settings. Fam 
Pract. 2008 Oct 1;25(5):321-7.  
36. Weiss JW, Mouttapa M, Chou C-P, Nezami E, Anderson Johnson C, Palmer PH, et al. 
Hostility, depressive symptoms, and smoking in early adolescence. J Adolesc. 2005 
Feb;28(1):49-62.  
37. Mendel JR, Berg CJ, Windle RC, Windle M. Predicting young adulthood smoking among 
adolescent smokers and nonsmokers. Am J Health Behav. 2012 Jul;36(4):542-54.  
38. Munafò MR, Hitsman B, Rende R, Metcalfe C, Niaura R. Effects of progression to cigarette 
smoking on depressed mood in adolescents: evidence from the National Longitudinal Study 
of Adolescent Health. Addiction. 2008 Jan;103(1):162-71.  
39. Ridner SL, Staten RR, Danner FW. Smoking and Depressive Symptoms in a College 
Population. J Sch Nurs. 2005 Aug 15;21(4):229-35.  
40. Duncan B, Rees DI. Effect of Smoking on Depressive Symptomatology: A Reexamination of 
Data from the National Longitudinal Study of Adolescent Health. Am J Epidemiol. 2005 Sep 
1;162(5):461-70.  
41. Goodman E, Capitman J. Depressive symptoms and cigarette smoking among teens. 
Pediatrics. 2000 Oct;106(4):748-55.  
42. Lechner W V., Janssen T, Kahler CW, Audrain-McGovern J, Leventhal AM. Bi-directional 
associations of electronic and combustible cigarette use onset patterns with depressive 
symptoms in adolescents. Prev Med (Baltim). 2017 Mar;96:73-8.  
43. Paschall MJ, Freisthler B, Lipton RI. Moderate Alcohol Use and Depression in Young 
Adults: Findings from a National Longitudinal Study. Am J Public Health. 2005 
Mar;95(3):453-7.  
44. Suerken CK, Reboussin BA, Sutfin EL, Wagoner KG, Spangler J, Wolfson M. Prevalence of 
marijuana use at college entry and risk factors for initiation during freshman year. Addict 
Behav. 2014 Jan;39(1):302-7.  
45. Martini S, Wagner FA, Anthony JC. The association of tobacco smoking and depression in 
adolescence: evidence from the United States. Subst Use Misuse. 2002;37(14):1853-67.  
46. Berg C, Choi WS, Kaur H, Nollen N, Ahluwalia JS. The Roles of Parenting, Church 
Attendance, and Depression in Adolescent Smoking. J Community Health. 2009 Feb 
1;34(1):56-63.  
47. Simantov E, Schoen C, Klein JD. Health-compromising behaviors: why do adolescents 
smoke or drink?: identifying underlying risk and protective factors. Arch Pediatr Adolesc 
Med. 2000 Oct;154(10):1025-33.  
48. Richardson A, He J-P, Curry L, Merikangas K. Cigarette smoking and mood disorders in U.S. 
adolescents: Sex-specific associations with symptoms, diagnoses, impairment and health 
services use. J Psychosom Res. 2012 Apr;72(4):269-75.  
49. Georgiades K, Boyle MH. Adolescent tobacco and cannabis use: young adult outcomes from 
the Ontario Child Health Study. J Child Psychol Psychiatry. 2007 Jul;48(7):724-31.  
50. Naicker K, Galambos NL, Zeng Y, Senthilselvan A, Colman I. Social, Demographic, and 
Health Outcomes in the 10 Years Following Adolescent Depression. J Adolesc Heal. 2013 
May;52(5):533-8.  
29 
 
51. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug Use and the Risk of Major 
Depressive Disorder, Alcohol Dependence, and Substance Use Disorders. Arch Gen 
Psychiatry. 2002 Nov 1;59(11):1039.  
52. Harder VS, Stuart EA, Anthony JC. Adolescent cannabis problems and young adult 
depression: male-female stratified propensity score analyses. Am J Epidemiol. 2008 Sep 
15;168(6):592-601.  
53. O’Loughlin J, O’Loughlin EK, Wellman RJ, Sylvestre M-P, Dugas EN, Chagnon M, et al. 
Predictors of Cigarette Smoking Initiation in Early, Middle, and Late Adolescence. J Adolesc 
Health. 2017 Sep 1;61(3):363-70.  
54. Weitzman ER. Poor mental health, depression, and associations with alcohol consumption, 
harm, and abuse in a national sample of young adults in college. J Nerv Ment Dis. 2004 Apr; 
192(4):269-77.  
55. Marmorstein NR. Anxiety disorders and substance use disorders: different associations by 
anxiety disorder. J Anxiety Disord. 2012 Jan;26(1):88-94.  
56. Meade Eggleston A, Woolaway-Bickel K, Schmidt NB. Social anxiety and alcohol use: 
evaluation of the moderating and mediating effects of alcohol expectancies. J Anxiety Disord. 
2004;18(1):33-49.  
57. Strahan EY, Panayiotou G, Clements R, Scott J. Beer, wine, and social anxiety: Testing the 
“self-medication hypothesis” in the US and Cyprus. Addict Res Theory. 2011 Aug 12; 
19(4):302-11.  
58. Wu P, Goodwin RD, Fuller C, Liu X, Comer JS, Cohen P, et al. The Relationship Between 
Anxiety Disorders and Substance Use Among Adolescents in the Community: Specificity and 
Gender Differences. J Youth Adolesc. 2010 Feb 13;39(2):177-88.  
59. Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM. Specificity of 
social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res. 
2008 Feb;42(3):230-9.  
60. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa 
Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; Ottawa 
(ON): Ottawa Health Research Institute; 1999. 
61. Hedges LV, Vevea JL. Fixed and random effects models in meta-analysis. Psychological 
Methods. 1998;3(4),486-504. 
62. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and 
adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56(2):455-63.  
63. Chaiton MO, Cohen JE, O’Loughlin J, Rehm J. A systematic review of longitudinal studies 
on the association between depression and smoking in adolescents. BMC Public Health. 2009 
Dec 22;9(1):356.  
64. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis 
use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 
2007 Jul 28;370(9584):319-28. 
65. Kedzior KK, Laeber LT. A positive association between anxiety disorders and cannabis use 
or cannabis use disorders in the general population- a meta-analysis of 31 studies. BMC 
Psychiatry. 2014 Dec 10;14(1):136.  
66. Windle, M. Alcohol Use Among Adolescents and Young Adults. Alcohol Research and 
Health. 2003;27(1),79-85. 
67. Brière FN, Rohde P, Seeley JR, Klein D, Lewinsohn PM. Comorbidity between major 
depression and alcohol use disorder from adolescence to adulthood. Compr Psychiatry. 2014 
Apr;55(3):526-33. 
30 
 
68. Rohde P, Lewinsohn PM, Kahler CW, Seeley JR, Brown RA. Natural course of alcohol use 
disorders from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry. 2001 
Jan;40(1):83-90. 
69. Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association 
between cannabis use and depression: a systematic review and meta-analysis of longitudinal 
studies. Psychol Med. 2014 Mar 24;44(4):797-810.  
70. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and 
depression. Addiction. 2003 Nov 1;98(11):1493-504.  
71. Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, 
causation, and context across stages of smoking. Psychol Bull. 2003 Mar;129(2):270-304.  
72. Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of 
anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain 
Behav. 2013 May;3(3):302-26. 
  
31 
 
Table 2.1: Definitions of mental health disorders and substance use 
 
Depression 
The center for epidemiologic studies depression scale (CES-D) (26, 32, 36-44) 
Beck depression inventory-II (BDI-II) (31) 
One item question: Whether respondents felt so sad or hopeless almost daily for two 
consecutive weeks that usual activities were interrupted (24) 
Youth self report checklist (8 self-reported symptoms of depression within the past 6 
months): I feel guilty, I cry a lot, I deliberately try to hurt myself, I think of killing 
myself, I feel lonely, I am unhappy, I feel that no one loves me, and I feel worthless 
(YSR) (45) 
A five-item question: within the past 12 months how often have you felt too tired to do 
things? Felt unhappy, sad, or depressed? Felt hopeless about the future? Felt nervous or 
tense? And worried too much about things? (46) 
Modified version of the children depression inventory (CDI) (47) 
Depression medication prescribed by a doctor or a nurse in the last 12 months (27) 
National institute of mental health diagnostic interview schedule for children version IV 
(NIMH-DISC, version IV): A structured diagnostic interview administered by lay 
interviewers to assess diagnostic criteria for mental disorders in children and adolescents, 
in accordance with the diagnostic and statistical manual of mental disorders, fourth 
edition (DSM-IV) (48) 
CIDI-SF: 12-month prevalence of major depressive disorder (MDD), based on the 
Composite International Diagnostic Interview-Short Form (49, 50) 
The university of Michigan composite international diagnostic interview (CIDI): A highly 
structured research diagnostic instrument developed for use by trained lay interviewers to 
assess the most common diagnoses among children, adolescents, and young adults as 
described in the DSM-III-R (51, 52) 
A 6-item question: During the past 3-month how often you have felt too tired to do 
things; had trouble going to sleep or staying asleep; felt unhappy, sad or depressed; felt 
hopeless about the future; felt nervous or tense; worried too much about things (53) 
Major depressive episode diagnosis: self-reported depression diagnosed by a medical 
professional with the past year (25) 
The short form (36) health survey (SF-36) (54) 
Mental health component of national health and nutrition examination 
survey (NHANES), assess diagnostic criteria for mental disorders in children and 
adolescents, in accordance with the diagnostic and statistical manual of mental disorders, 
third edition (DSM-III) (30, 55) 
Anxiety 
Social interaction anxiety scale (SIAS) (28, 29, 56, 57)  
Diagnostic interview schedule for children, version IV (DISC-IV) (25, 34, 58) 
Primary care evaluation of mental disorders (PRIME-MD) (35) 
Schedule for affective disorders and schizophrenia for school-age children (K-SADS) (33, 
59) 
Anxiety medication prescribed by a doctor or a nurse in the last 12 months (27) 
National Institute of Mental Health Diagnostic Interview for children (NIMHD) (48) 
Alcohol 
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 Ever drinkers: Drinking at least once within a lifetime (51) 
Light drinkers: Consuming less than three drinks per week (30) 
Moderate drinkers: Drinking without engaging in heavy episodic or binge drinking in the 
past two weeks (54) 
Moderate drinkers: Drinking no more than 1 to 2 drinks per occasion in the past year, and 
no intoxication or heavy drinking in the past year (25, 43)  
Moderate to heavy drinkers: Consuming more than 3 drinks per week (30) 
Regular drinkers: Drink at least once a month or more frequently and consume at least 
three to four drinks when drinking (47) 
Current drinkers: Drinking at least one time during the past 30 days (32) 
Daily drinking questionnaire (DDQ): The total number of standard alcoholic drinks 
consumed during the past week by summing the number of drinks reported for each day 
(28) 
Frequent/heavy drinkers: Those who over the past 6 months had a drink at least once a 
week or had been drunk at least once (58) 
Binge drinkers: Men/women as drinking five/four or more drinks per drinking occasion at 
least once in the past two weeks (25, 31, 32, 43, 50, 54, 56)  
Alcohol use disorders identification test (AUDIT) (28, 57) 
Diagnostic interview schedule for children, version IV, alcohol use disorder (DISC-IV, 
AUD) (34) 
Primary care evaluation for mental disorders, alcohol use disorder (PRIME-MD, AUD) 
(35) 
Longitudinal interval follow-up evaluation and structured clinical interview for DSM-IV, 
non-patient version, alcohol use disorder (LIFE and SCID-I/NP, AUD) (59) 
 
Cannabis 
Ever cannabis users: Using cannabis at least once within a lifetime (44, 51) 
Any use of cannabis or hashish in the past six months (49) 
Infrequent cannabis users: Using cannabis at least once per year but not more than once 
per month (55) 
Infrequent cannabis users: Less than weekly cannabis use (29) 
Frequent cannabis users: Weekly or more cannabis use (29) 
Current cannabis users: Cannabis use at least one time during the past 30 days (26, 31, 32, 
39) 
The substance abuse module of the composite international diagnostic interview, cannabis 
use disorder (CIDI-SAM, CUD) (34, 35, 52, 55, 59) 
Tobacco 
Ever smokers: Smoking at least once within a lifetime (33, 36, 37, 38, 51) 
Current smokers: Smoking at least one time during the past 30 days (24, 30, 31, 32, 39, 
40, 41, 42, 45, 46) 
Regular smokers: Smoking several cigarettes or more per week (47) 
Regular smokers: Self-report measure: I’m a regular smoker/I’m a heavy smoker (27) 
Daily smokers: Daily consumption of cigarettes or cigars for a continuous 30-day period 
or longer (27, 33, 49, 50, 58) 
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Table 2.2: Study characteristics of final references 
 
First author's 
name, year, 
country 
Sample size Target 
population 
Substance use 
measure 
Mental health 
disorders 
assessment 
Controlled 
variables 
OR (95% CI) 
Association between Depression and Alcohol use 
Cross-Sectional Studies 
Elissa Weitzman, 
2004, U.S. (54) 
27687 College students  
aged 18-24 
Binge/ 
non-drinkers 
The 5-item 
subscale of 
SF36  
Age, sex, 
ethnicity 
Adjusted: 
1.05 (0.96-1.14) 
Martha Kubik,  
2005, U.S. (32) 
3466 Grade 7 students 
 
Heavy/ 
non-drinkers 
CES-D,  
cut-off point of 
16. 
Age, ethnicity, 
SES, smoking, 
cannabis, and 
inhalants use 
Adjusted:  
2.03 (1.30-3.17) 
Susan Roberts,  
2009, U.S. (31) 
418 College students Binge/ 
non-drinkers 
BDI-II,  
cut-off point of 
20 
- Crude:  
0.99 (0.61-1.58) 
Elisabeth Simantov,  
2000, U.S. (47) 
5513 Grade 7-12 
students 
Regular/ 
non-drinkers  
Modified 
version of CDI, 
cut-off point of 
9 
- Crude:  
2.08 (1.79-2.42) 
Linda Richter,  
2015, U.S. (25) 
24445 Adolescents 
aged 12-20 
Binge/ 
non-drinkers 
Diagnosed 
depression  
(self-reported)  
Sex, ethnicity, 
and age 
Adjusted:  
1.45 (1.11-1.91) 
Eleanor Hanna,  
2001, U.S. (30) 
719 Adolescents 
aged 12-16 
Moderate/ 
non-drinkers 
Diagnostic 
interview 
schedule, DSM-
III 
Age, sex, 
ethnicity, family 
poverty level, 
school problem, 
smoking status 
Adjusted:  
3.31 (1.39-7.90) 
Longitudinal studies: Alcohol use (exposure)  Depression (outcome) 
Mallie Paschall,  
2005, U.S. (43) 
13892 Grade 6-12 
students 
Moderate/ 
non-drinkers 
CES-D,  
cut-off point of 
16. 
- Crude:  
1.17 (1.11-1.23) 
  
3
4
 
 
David Brook,  
2002, U.S. (51) 
736 Adolescents 
aged 14, 13-year 
follow-up 
Ever/ 
never users 
Modified 
version of CIDI 
Age, sex, 
parental 
educational 
level, family 
income, prior 
psychiatric 
disorders 
Adjusted:  
1.72 (1.35-2.20) 
Longitudinal study: Depression (exposure)  Alcohol use (outcome) 
Kiyuri Naicker,  
2012, Canada (50) 
681 Adolescents 
aged 16-17, 10-
year follow-up 
Heavy/ 
non-drinkers 
CIDI-SF,  
cut-off point of 
5 
Sex and SES 
 
Adjusted: 
1.78 (1.10-2.88) 
 
Association between Depression and Cannabis use 
Cross-Sectional Studies 
Lee Ridner,  
2005, U.S. 
(39) 
895 College 
students  
aged 18-24 
Current/ 
non-users 
CES-D,  
cut-off point of 16 
- Crude:  
1.27 (1.00-1.61) 
Susan Roberts,  
2009, U.S. 
(31) 
418 College 
students 
Current/ 
non-users 
BDI-II,  
cut-off point of 20 
- Crude:  
1.99 (1.23-3.22) 
Martha Kubik,  
2005, U.S. 
(32) 
3466 Grade 7 
students 
 
Current/ 
non-users 
CES-D,  
cut-off point of 16 
Age, ethnicity, SES, 
smoking, alcohol, and 
inhalants use. 
Adjusted:  
1.02 (0.66-1.57) 
Longitudinal studies: Cannabis use (exposure)  Depression (outcome) 
Daniel Rasic,  
2012, Canada 
(26) 
976 Grade 10 
students, 
2-year follow-
up 
Current/ 
non-users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Sex Adjusted:  
1.24 (1.05-1.46) 
Katholiki 
Georgiades,  
2007, Canada 
(49) 
1282 Adolescents 
aged 12-16, 
14-year 
follow-up 
Past 6-
month/non-
users  
CIDI-SF Physical health, life 
satisfaction, personal 
income, years of education 
Adjusted:  
1.97 (0.81-4.81) 
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David Brook,  
2002, U.S. 
(51) 
736 Adolescents 
aged 14, 10-
year follow-up 
Ever/ 
never users 
Modified version of 
CIDI 
Age, sex, parental 
educational level, family 
income, prior psychiatric 
disorders 
Adjusted:  
1.36 (1.14-1.62) 
Naomi 
Marmorstein,  
2011, U.S. 
(55) 
1252 Adolescents 
aged 17,  
A 6-year 
follow-up 
CUD/ 
non-users 
The structured 
clinical interview 
for DSM-III-R. 
MDD by age 17 and 
gender 
Adjusted:  
1.86 (1.11-3.11),  
Valerie 
Harder,  
2008, U.S. 
(52) 
1494 Adolescents 
aged 12-16, 7-
year follow-up 
CUD/ 
non-users 
CIDI, DSM IV 
diagnostic criteria 
for major 
depression. 
Ethnicity, family income, 
free lunch, tobacco, 
alcohol, and other illegal 
drug use, parental 
monitoring, concentration, 
behavior problems, 
shyness, anxiety 
symptoms, intervention 
status 
Adjusted:  
1.33 (0.70-2.53) 
Longitudinal study: Depression (exposure)  Cannabis use (outcome) 
Cynthia 
Suerken,  
2014, U.S. 
(44)  
3146 College 
students,  
A 6-month 
follow-up 
Ever/ 
never users 
CES-D, Iowa short 
form 
Sex, ethnicity, parental 
education and spending 
money available, varsity 
athlete, club, intramural 
sports, member of a 
sorority/fraternity, attend 
religious services, live on 
campus, relationship status, 
current use of tobacco, 
alcohol, and lifetime use of 
other illicit drugs 
Crude:  
1.03 (1.01-1.05) 
 
  
  
3
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Association between Depression and Tobacco use 
Cross-Sectional Studies 
Lee Ridner,  
2005, U.S. 
(39) 
895 College 
students  
aged 18-24 
Current/ 
non-users 
CES-D,  
cut-off point of 16 
- Crude:  
1.49 (1.18-1.90) 
Susan Roberts,  
2009, U.S. 
(31) 
418 College 
students,  
aged 18-21 
Current/ 
non-users 
BDI-II,  
cut-off point of 20 
- Crude:  
2.08 (1.29-3.36) 
Elisabeth 
Simantov, 
2000, U.S. 
(47) 
5513 Grade 7-12 
students  
Regular/ 
non-users 
Modified version of 
CDI, cut-off point 
of 9  
- Crude:   
2.47 (2.06-2.97) 
Sung Chung,  
2014, U.S. 
(24) 
11848 Grade 9-11 
students 
Current/ 
non-users 
1 item question - Crude:  
1.33 (1.16-1.53) 
Shahm 
Martini,  
2002, U.S. 
(45) 
11201 Adolescents  
aged 12-17 
Current/ 
non-users 
YSR,  
cut-off point of 3 
Age, ethnicity, school 
attendance, site, substance 
use behaviors 
Crude:  
1.83 (1.67-2.01) 
Carla Berg,  
2008, U.S. 
(46) 
299 Adolescents  
aged 10-19 
Current/ 
non-users 
A 5-item question,  
cut-off point of 21 
Age, sex, ethnicity, church 
attendance, perceived 
parental attitude 
Crude:  
3.83 (1.65-8.88)  
Martha Kubik,  
2005, U.S. 
(32) 
3466 Grade 7 
students 
 
Current/ 
non-users 
CES-D, cut-off 
point of 16 
Age, ethnicity, SES, all 
other substance use 
behaviors 
Adjusted:  
1.56 (1.14-2.14) 
Gilat Grunau,  
2009, Canada 
(27) 
6943 Students  
aged 13-18 
Current/ 
non-users 
Prescribed 
depression 
medications 
Age, sex, ethnicity, 
parent(s), sibling(s), 
peer(s) smokes, anxiety 
Adjusted: 
2.59 (1.79-3.73) 
Amanda 
Richardson,  
2012, U.S. 
(48) 
1884 Adolescents  
aged 12-15 
Ever/ 
never users  
NIMH-DISC-IV Age, ethnicity, attending 
school, poverty index ratio, 
live with smokers, anxiety 
disorders 
Adjusted:  
2.80 (1.13-6.91) 
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Eleanor 
Hanna,  
2001, U.S. 
(30) 
719 Adolescents  
aged 12-16 
Current/ 
non-users  
Diagnostic 
interview schedule, 
DSM-III 
Age, sex, ethnicity, family 
poverty status, school 
problem, drinking status 
Adjusted:  
0.98 (0.33-2.90) 
Longitudinal studies: Tobacco use (exposure)  Depression (outcome) 
Brian Duncan, 
2005, U.S. 
(40) 
13068 Students grade 
7-12, 1-year 
follow-up 
Current/ 
non-users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Disability, age, ethnicity, 
household, parental 
education, county-level 
variables 
Crude: 
2.37 (2.02-2.77) 
Elizabeth 
Goodman,  
2000, U.S. 
(41) 
8704 Adolescents 
aged 11-22, 1-
year follow-up 
Current/ 
non-users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Age, sex, ethnicity, 
parental education 
Crude:  
2.31 (1.83-2.92) 
Katholiki 
Georgiades,  
2007, Canada 
(49) 
1282 Adolescents 
aged 12-16, 
14-year 
follow-up 
Daily/ 
non-users 
CIDI-SF Physical health, life 
satisfaction, personal 
income, years of education 
Adjusted:  
1.93 (1.01-3.70) 
David Brook,  
2002, U.S. 
(51) 
736 Adolescents 
aged 14,  
A 13-year 
follow-up 
Ever/ 
never users 
Modified version of 
CIDI 
Age, sex, parental 
educational level, family 
income, prior psychiatric 
disorders 
Adjusted:  
1.18 (1.01-1.39) 
Longitudinal studies: Depression (exposure)  Tobacco use (outcome) 
Elizabeth 
Goodman,  
2000, U.S. 
(41) 
6947 Adolescents 
aged 11-22, 1-
year follow-up 
Current/ 
non-users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Age, sex, ethnicity, 
education 
Crude:  
2.81 (1.67-4.74) 
Kiyuri 
Naicker,  
2012, Canada 
(50) 
681 Adolescents 
aged 16-17, 
10-year 
follow-up 
Daily/ 
non-users 
CIDI-SF,  
cut-off point of 5 
Sex and SES Adjusted:  
2.89 (1.53-5.45) 
Jie Wu Weiss,  
2004, U.S. 
(36) 
1699 Grade 6 
students,  
Ever/ 
never users 
CES-D,  
cut-off point of 16 
change in depression and 
hostility, sex, ethnicity, 
SES 
Adjusted: 
1.76 (1.30-2.38) 
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A 1-year 
follow-up 
Jennifer 
Mendel,  
2012, U.S. 
(37) 
1205 Grade 10-11 
students,  
A 5-year 
follow-up 
Ever/ 
never users 
CES-D,  
cut-off point of 16 
Sex, parental marital 
status, family income, 
education level, marital 
status, children, GPA, 
delinquency, stressful life 
events, family support, 
quality of friendship, 
parental smoking, 
adolescent alcohol, 
cannabis use, extent of 
alcohol problems, peers 
who drink or use drugs, 
change in CESD and 
alcohol use 
Adjusted:  
0.97 (0.92-1.03) 
Jennifer 
O’Loughlin, 
2016, Canada 
(53) 
690 Grade 5 
students,  
7-year follow-
up 
Ever/ 
never users 
6-item question 
 
Age, sex, mother’s 
education 
Adjusted:  
1.34 (1.16-1.56) 
Marcus 
Munafo,  
2007, U.S. 
(38) 
12149 Grade 7-12 
students, 1-
year follow-up 
Ever/ 
never users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Age, sex, ethnicity, 
depressed mood, 
parental/peer tobacco, 
alcohol use, delinquency 
score 
Adjusted:  
1.13 (1.03-1.25) 
William 
Lechner,  
2016, U.S. 
(42) 
2460 Grade 9 
students,  
A 1-year 
follow-up 
Ever/ 
never users 
CES-D, cut-off 
point of 22 (M) and 
24 (F) 
Age, sex, ethnicity, school, 
living situation, parental 
education, use of alcohol 
and other tobacco products  
 
Adjusted:  
1.02 (1.01-1.04) 
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Association between Anxiety and Alcohol use 
Cross-Sectional Studies 
Margo 
Villarosa, 
2014, U.S. 
(28) 
532 College 
students  
aged 18-22  
Daily use, 
AUDIT 
SIAS - Crude:  
1.61 (1.29-2.00) 
Meade 
Eggleston,  
2003, U.S. 
(56) 
284 College 
students  
aged 17-23 
Binge/ 
non-drinkers 
SIAS - Crude:  
1.55 (1.15-2.10) 
Esther Strahan,  
2010, U.S. 
(57) 
697 College 
students  
aged 17-27  
AUDIT SIAS - Crude:  
1.04 (1.01-1.08) 
Ping Wu,  
2009, U.S. 
(58) 
781 Adolescents  
aged 13-17 
Frequent, 
heavy/non-
drinkers 
DISC Age, ethnicity, public 
assistance, not living with 
parents, parental 
drug/alcohol problems, site 
Adjusted:   
1.74 (1.07-2.81) 
Linda Richter,  
2015, U.S. 
(25) 
24445 Adolescents  
aged 12-20 
Binge/ 
non-drinkers 
Diagnosed anxiety  
(self-reported) 
Age, sex, ethnicity Adjusted:  
1.54 (1.12-2.12) 
Robert 
Roberts,  
2007, U.S. 
(34) 
4175 Adolescents  
aged 11-17 
AUD  DISC-IV Mood, conduct 
oppositional, and ADHD 
disorders. 
Crude:  
1.57 (0.72-3.40) 
Nancy Low,  
2008, U.S. 
(35) 
632 Adolescents  
aged 13-19 
AUD PRIME-MD Age, sex, ethnicity, sample 
site, mood disorders 
Adjusted:  
3.80 (1.21-
11.91) 
Longitudinal study: Anxiety (exposure)  Alcohol use (outcome) 
Julia Buckner,  
2008, U.S. 
(59) 
816 Students aged 
15-17, 14-year 
follow-up 
AUD K-SADS  Sex, conduct, mood, 
CUDs, T1 AUD excluded 
Adjusted:  
2.16 (0.82-5.69) 
 
  
4
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Association between Anxiety and Cannabis use 
Cross-Sectional Studies 
Julia Buckner,  
2008, U.S. 
(29) 
 College 
students 
aged 18-26 
Frequent/ 
non-users  
SIAS - Crude:  
1.23 (0.88-1.73) 
Robert 
Roberts,  
2007, U.S. 
(34) 
4175 Adolescents  
aged 11-17 
CUD DISC-IV Mood, conduct 
oppositional, and ADHD 
disorders 
Crude:  
1.38 (0.70-2.75)  
Nancy Low,  
2008, U.S. 
(35) 
632 Adolescents  
aged 13-19 
CUD PRIME-MD  Age, sex, ethnicity, sample 
site, mood disorders 
Crude:  
1.40 (0.40-4.70) 
Longitudinal study: Anxiety (exposure)  Cannabis use (outcome) 
Julia Buckner,  
2008, U.S. 
(59) 
816 Students aged 
15-17, 14-year 
follow-up 
CUD K-SADS  Sex, conduct, mood, 
AUDs, T1 CUD excluded 
Adjusted:  
3.28 (1.14-9.40) 
  
  
4
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Association between Anxiety and Cannabis use 
Cross-Sectional Studies 
Gilat Grunau,  
2009, Canada 
(27) 
6943 Students  
aged 13-18 
Current/ 
non-users 
Prescribed anxiety 
medications 
Sex, ethnicity, age, 
parent(s), sibling(s), 
peer(s) smokes, depression 
Adjusted:  
1.83 (1.05-3.22) 
Ping Wu,  
2009, U.S. 
(58) 
781 Adolescents  
aged 13-17 
Daily/ 
non-users 
DISC Age, ethnicity, public 
assistance, not living with 
parents, parental 
drug/alcohol problems, 
site. 
Adjusted:  
3.14 (1.69-5.81) 
Amanda 
Richardson,  
2012, U.S. 
(48) 
1884 Adolescents  
aged 12-15 
Ever/ 
never users  
NIMH-DISC-IV Age, ethnicity, attending 
school, poverty index ratio, 
live with smokers, 
depressive disorder 
Adjusted:  
4.70 (1.61-
13.75) 
Longitudinal study: Tobacco use (exposure)  Anxiety (outcome) 
Renee 
Goodwin,  
2005, U.S. 
(33) 
940 Students aged 
14-18, anxiety: 
young adults 
mean age 24.2 
Ever, daily/ 
non-users 
K-SADS - Crude:  
1.88 (1.47-2.41) 
 
Longitudinal study: Anxiety (exposure)  Tobacco use (outcome) 
Renee 
Goodwin,  
2005, U.S. 
(33) 
940 Students aged 
14-18, tobacco 
use: young 
adults mean 
age 24.2 
Ever, daily/ 
non-users 
K-SADS - Crude:  
1.38 (0.83-2.29) 
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Table 2.3: Pooled estimate (overall and by study design) 
 
 Study Designs N OR (95% CI) I2% and p-
value 
Depression 
and  
Alcohol use 
Overall 9 1.50 (1.24-1.83) 90.54, <0.001 
Cross-Sectional 6 1.57 (1.09-2.26) 92.89, <0.001 
Longitudinal: Alcohol use at baseline 2 1.39 (0.95- 2.03) 89.24, <0.001 
Longitudinal: Depression at baseline 1 1.78 (1.10-2.88) n/a 
Depression 
and 
Cannabis use 
 
Overall 9 1.29 (1.10-1.51) 74.79, <0.01 
Cross-Sectional 3 1.34 (0.97-1.84) 53.26, 0.12 
Longitudinal: Cannabis use at 
baseline 
5 1.33 (1.19-1.49) 0.00, 0.53 
Longitudinal: Depression at baseline 1 1.03 (1.01-1.05) n/a 
Depression 
and  
Tobacco use 
 
Overall 20 1.65 (1.43-1.92) 96.23, <0.01 
Cross-Sectional 10 1.87 (1.55-2.25) 78.60, <0.01 
Longitudinal: Tobacco use at baseline 4 1.87 (1.23-2.85) 92.95, <0.01 
Longitudinal: Depression at baseline 7 1.22 (1.09-1.37) 89.56, <0.001 
Anxiety  
and  
Alcohol use 
Overall 8 1.54 (1.19-2.00) 81.52, <0.001 
Cross-Sectional 7 1.51 (1.16-1.97) 83.28, <0.001 
Longitudinal: Alcohol use at baseline - - - 
Longitudinal: Anxiety at baseline 1 2.16 (0.82-5.69) n/a 
Anxiety  
and 
Cannabis use 
 
Overall 4 1.36 (1.02-1.81) 0.39, 0.39 
Cross-Sectional 3 1.27 (0.94-1.70) 0.00, 0.94 
Longitudinal: Cannabis use at 
baseline 
- - - 
Longitudinal: Anxiety at baseline 1 3.28 (1.14-9.40) n/a 
Anxiety  
and  
Tobacco use 
Overall 4 2.21 (1.54-3.17) 46.17, 0.13 
Cross-Sectional 3 2.67 (1.62-4.37) 33.12, 0.22 
Longitudinal: Tobacco use at baseline 1 1.88 (1.47-2.41) n/a 
Longitudinal: Anxiety at baseline 1 1.38 (0.83-2.29) n/a 
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Table 2.4: Subgroup Analysis 
 
 Subgroup 
Analysis 
 N OR (95% CI) I2% and p-
value 
p-
value 
D
ep
re
ss
io
n
 a
n
d
  
A
lc
o
h
o
l 
u
se
 
Point Estimate Crude 3 1.37 (0.87-2.18) 96.08, <0.001 0.56 
Adjusted 6 1.62 (1.19-2.19) 84.60, <0.001 
Target 
Population 
Adolescents 7 1.69 (1.28-2.25) 90.63, <0.001 0.28 
Young adults 3 1.28 (0.83-1.97) 82.52, <0.001 
Severity of 
MHDs1 
Symptoms 5 1.37 (1.08-1.75) 94.04, <0.001 0.21 
Disorders 4 1.67 (1.38-2.02) 14.68, 0.32 
Intensity of 
substance use  
Not binge 
drinkers 
6 1.61 (1.29-2.01) 79.79, <0.001 0.06 
Binge drinkers 6 1.21 (0.99-1.47) 87.67, <0.001 
D
ep
re
ss
io
n
 a
n
d
 
C
a
n
n
a
b
is
 u
se
 
Point Estimate Crude 3 1.27 (0.95-1.69) 80.29, <0.001 0.85 
Adjusted 6 1.31 (1.17-1.46) 0.00, 0.48 
Target 
Population 
Adolescents 6 1.34 (1.17-1.54) 9.96, 0.35 0.46 
Young adults 4 1.22 (0.99-1.51) 72,62, 0.01 
Severity of 
MHDs 
Symptoms 5 1.20 (1.01-1.42) 73.16, <0.001 0.16 
Disorders 4 1.41 (1.21-1.65) 0.00, 0.60 
Intensity of 
substance use 
Cannabis use 7 1.25 (1.06-1.47) 77.10, <0.001 0.23 
CUD2 2 1.63 (1.09-2.44) 0.00, 0.42 
D
ep
re
ss
io
n
 a
n
d
 
T
o
b
a
cc
o
 u
se
 
Point Estimate Crude 8 1.99 (1.65-2.40) 86.62, <0.001 <0.001 
Adjusted 12 1.30 (1.16-1.45) 87.12, <0.001 
Target 
Population 
Adolescents 18 1.67 (1.43-1.96) 96.56, <0.001 0.40 
Young adults 3 1.37 (0.89-2.12) 84.18, <0.001 
Severity of 
MHDs 
Symptoms 14 1.61 (1.36-1.89) 97.18, <0.001 0.48 
Disorders 6 1.91 (1.22-2.97) 78.86, <0.001 
Intensity of 
substance use 
Ever smokers 7 1.14 (1.04-1.25) 84.89, <0.001 <0.001 
Current 
smokers 
14 1.90 (1.62-2.23) 82.65, <0.001 
A
n
x
ie
ty
 a
n
d
  
A
lc
o
h
o
l 
u
se
 
Point Estimate Crude 4 1.37 (1.00-1.88) 86.27, <0.001 0.3 
Adjusted 4 1.70 (1.32-2.18) 0.00, 0.47 
Target 
Population 
Adolescents 5 1.69 (1.33-2.14) 0.00, 0.64 0.29 
Young adults 3 1.35 (0.96-1.90) 90.40, <0.001 
Severity of 
MHDs 
Symptoms 3 1.35 (0.96-1.90) 90.40, <0.001 0.29 
Disorders 5 1.69 (1.33-2.14) 0.00, 0.64 
Intensity of 
substance use 
Alcohol use 6 1.49 (1.26-1.76) 0.00, 0.88 0.59 
AUD3 5 1.71 (1.05-2.79) 83.88, <0.001 
A
n
x
ie
ty
 a
n
d
 
C
a
n
n
a
b
is
 u
se
 Point Estimate Crude 2 1.26 (0.93-1.71) 0.00, 0.76 0.19 
Adjusted 2 2.28 (1.00-5.20) 5.37, 0.30 
Target 
Population 
Adolescents 3 1.71 (1.02-2.89) 0.00, 0.38 0.29 
Young adults 1 1.23 (0.88-1.73) n/a 
Severity of 
MHDs 
n/a 
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Intensity of 
substance use 
Cannabis 
use 
1 1.23 (0.88-1.73) n/a 0.29 
CUD 3 1.71 (1.02-2.89) 0.00, 0.38 
A
n
x
ie
ty
 a
n
d
 
T
o
b
a
cc
o
 u
se
 
Point Estimate Crude 1 1.78 (1.42-2.22) n/a 0.14 
 Adjusted 3 2.67 (1.62-4.37) 33.125, 0.22 
Target 
Population 
n/a 
Severity of 
MHDs 
n/a 
Intensity of 
substance use 
Ever 3 1.62 (0.67-3.92) 69.87, 0.04 0.58 
 Current 4 2.10 (1.69-2.62) 0.00, 0.52 
1 Mental Health Disorders, 2 Cannabis Use Disorder, 3 Alcohol Use Disorder 
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Figure 2.1: PRISMA Diagram 
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Figure 2.2: Examining the directionality in longitudinal studies (Forest plots)  
 
The association between tobacco use at baseline and depression at follow-up 
 
 
The association between depression at baseline and tobacco use at follow up  
 
 
 
The association between cannabis use at baseline and depression at follow up 
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Chapter 3: Examining the association between mental health disorders and 
substance use among Canadian post-secondary students 
 
3.1 Abstract 
 
Background: Mental health disorders and substance use are reported to be common among post-
secondary students. Co-occurrence of mental health disorders and substance use may be due to a 
number of inter-complex but closely inter-linked factors. In Canada, the independent association 
between mental health disorders and substance use is not clearly established. Therefore, the 
purpose of this study was to examine the association between mental health disorders and 
substance use among Canadian post-secondary students.  
 
Methods: This study was conducted using the spring 2016, ACHA-NCHA II survey. It includes 
43,780 college students from 41 Canadian post-secondary institutions. The exposure variables of 
interest were alcohol, cannabis, and tobacco use and the outcome variables of interest were 
diagnosis or treatment for depression and/or anxiety. Descriptive statistics, univariate and 
multivariate logistic regression models were used to analyze our data.  
 
Results: Our study found that 14.7% of post-secondary students were diagnosed or treated for 
depression and 18.4% for anxiety within the past 12-months. Among current (past 30-days) 
substance use, it was reported that alcohol (69.3%), cannabis (17.9%), and tobacco (11%) were 
the most common. There was a significant association between depression and current tobacco 
use (OR=1.36, 95% CI: 1.22-1.52, p<0.001) and current cannabis use (OR=1.17, 95% CI: 1.05-
1.31, p<0.001). There was also a gender-specific association between anxiety and female alcohol 
users (OR=1.41, 95% CI: 1.24-1.62, p<0.001). 
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Conclusion: The results of this study showed significant associations between depression, 
tobacco use and cannabis use, and anxiety and alcohol use in females. These conditions should 
be screened concurrently for improved outcomes. Results of this study may help inform student 
health services, university administrators, and healthcare professionals in their efforts to design 
and implement comprehensive educational initiatives, appropriate policies, and effective health 
promotion strategies. 
 
Keywords: Depression, anxiety, alcohol, cannabis, tobacco, post-secondary students 
 
3.2 Introduction  
 
For many, young adulthood is a critically important time in their lives as they transition from 
high school to post-secondary studies to pursue greater educational opportunities, develop 
personal relationships, and achieve their career goals. Post-secondary education provides 
students with many opportunities and challenges for their personal development and growth. 
Among the challenges faced are increased independence and responsibility that may at times, 
lead to highly stressful situations. The competitive nature and pressurized academic environment 
of post-secondary education makes some students vulnerable to develop mental health disorders 
and/or substance use problems either independently or concurrently (1). These conditions may 
affect their academic progress, personal development, and professional life.  
 
The prevalence of mental health disorders among post-secondary students is estimated to be 
approximately 20%, worldwide (2). Anxiety (11.7%) and depressive disorders (4.5%) were the 
two most common mental health disorders found in this population (2). Despite the high 
proportion of students affected by mental health disorders, a considerable number are 
undiagnosed and/or do not receive adequate treatment (2). Students with mental health disorders 
(such as anxiety or depressive disorders) encounter difficulties on a personal (academic 
performance and coping abilities), interpersonal (ability to handle work/life responsibilities and 
engagement in social activities), and institutional (time to graduation and graduation rate) level, 
which negatively impacts their health and well-being (3, 4).  
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Another serious problem facing post-secondary students is substance use. Alcohol, cannabis, and 
tobacco are the three most common substances used among post-secondary students (5). In 
Canada, the prevalence of current alcohol (83%), cannabis (30%), and tobacco (18%) use is 
highest among individuals aged 20-24 years old, a large proportion of whom are post-secondary 
students (6). College students may use substances as a way to escape from school/work/financial 
stresses, social pressures, and as a means to compensate for feelings of shyness, inadequacy or 
low self-esteem. However, substance use is reported to lead to several adverse outcomes 
including poor academic performance (7), unintentional injuries (8), and increased engagement 
in other risky behaviors (9, 10).  
 
Mental health disorders and substance use are closely linked and pose a growing public health 
concern for many university campuses across Canada. It is reported that individuals with 
concurrent disorders experience more serious medical, social, and emotional problems (11). 
Affected individuals are also more often refractory to treatments and require more extensive 
healthcare support (12).  Mental health disorders and substance use can co-occur due to a variety 
of reasons including 1) common risk factors (such as biological factors or traumatic events); 2) 
self-medication hypothesis (individuals already suffering from mental health disorders may 
exhibit a maladaptive response and self-medicate by using substances to forget bad feelings, 
problems, and to relieve symptoms of their mental health disease); 3) substance use-induced 
mental health problems (individuals may develop a mental health problem as a direct [i.e., 
pharmacogenic] consequence of their substance use); and 4) substance use-related mental health 
problems (individuals may develop a mental health problem as an indirect [i.e., socio-economic 
stressors, unemployment, dysfunctional relationships] consequence of their substance use) (11). 
However, due to the multifactorial nature of this problem, it is not yet clear whether an 
independent association exists between mental health disorders and substance use as the 
literature reports inconsistent findings (13-16).  
 
There has been considerable attention given to mental health disorders and substance use among 
high school students; however, less is known about post-secondary students. Moreover, much of 
the published research examining the association between mental health disorders and substance 
use has been conducted in countries other than Canada. Therefore, the purpose of this study was 
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to examine the association between mental health disorders and substance use among Canadian 
post-secondary students.  
 
3.3 Methods  
 
This study used data from the American College Health Association - National College Health 
Assessment II (ACHA-NCHA II) - Canadian Reference Group survey, spring 2016. The 
population of interest in this national survey was post-secondary students. The 2016, ACHA-
NCHA II survey consists of data from 43,780 students representing 41 Canadian post-secondary 
institutions. These institutions either surveyed all their students or used a representative random 
sampling method. The overall participation rate was 19.2% (5).  
 
3.3.1 Outcome variables  
 
The outcome variables of interest in this study were: 1) history of depression (yes/no), and 2) 
history of anxiety (yes/no). Respondents were specifically asked to indicate whether they had: 1) 
been diagnosed or treated by a medical professional for depression within the past 12-months, 
and/or 2) been diagnosed or treated by a medical professional for anxiety within the past 12- 
months.  
 
3.3.2 Explanatory variables 
 
Substance use was the primary exposure of interest. The three variables analysed were: 1) 
alcohol use (never/former/current user), 2) cannabis use (never/former/current user), and 3) 
tobacco use (never/former/current user). Responses were re-categorised to 1) never users (never 
used the substance), 2) former users (used the substance but not within the past 30-days), and 3) 
current users (used the substance within the past 30-days).  
 
3.3.3 Demographics and Other Factors 
 
Sociodemographic variables and other factors were reported in this study. The gender variable 
had three levels: male, female, and non-binary (those who cannot describe themselves as solely 
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male or female). Age groups were re-categorised as follows: 1) 18 to 20 years old, 2) 21 to 23 
years old, and 3) 24 years old or older. Ethnicity was self-reported from the following question:  
Do you usually describe yourself as White, Black, Hispanic/Latino, Asian/Pacific Islander, 
American Indian/Alaskan Native/Native Hawaiian, Biracial/Multiracial, or Other? Participants 
were also asked about their marital status (single, married, separated/divorced, or other). 
Additionally, there were questions that described the following: international student (yes/no), 
housing (live with their parents/on-campus/off-campus), enrollment status (full-time/part-
time/other), study status (undergraduate/graduate/other), and Grade Point Average (GPA) 
(A/B/C/D or F/not applicable).  
 
Questions pertaining to other substance use (never/former/current user) included: cocaine, 
methamphetamine, sedatives, hallucinogens, opiates, inhalants, MDMA, and other club and 
illegal drugs. Participants were then re-categorized into three groups: 1) never users (never used 
any of the other substances), 2) former users (used but not within the past 30-days), and 3) 
current users (used within the past 30-days). Questions pertaining to other mental health 
disorders (yes/no) were re-categorised based on participant’s response to the following 
questions: Have you been diagnosed or treated by a medical professional for any of the following 
mental health disorders: anorexia, attention-deficit hyperactivity disorder (ADHD), bipolar 
disorder, bulimia, insomnia, and schizophrenia within the past 12-months. If yes, the participant 
was coded as yes for the other mental health disorders variable. 
 
3.3.4 Data analysis  
 
All statistical analyses were computed using SAS version 9.4. Descriptive statistics for the 
exposure and outcome variables of interest and other co-variates were examined (Table 3.1). 
Univariate analysis was conducted to assess the crude association of one explanatory variable at 
a time with the outcome variable of interest (depression or anxiety) (Table 3.2). During 
univariate analysis, variables with a significance level of less than 0.15 were screened and were 
included in the multivariate analysis. 
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Two separate multivariable logistic regression (MLR) models were built using depression and 
anxiety as the outcomes of interest. Both models used substance use behavior (alcohol, cannabis, 
and tobacco use) as the main exposures while controlling for demographic characteristics and 
other factors as presented in Table 3.3. Multicollinearity among independent variables was 
assessed using the Variance Inflation Factor (VIF<2.5 indicated no multicollinearity). Backward 
selection strategy was used to build the final models. The confounding effect of statistically 
insignificant variables was assessed before they were removed from the models. A change of 
10% or more in the regression coefficient of the primary predictor suggested that the variable is a 
confounder. All potential two-way interactions were assessed using a level of significance of 
0.05 (α=0.05). A diagnostic test (AIC value) was used to check goodness of fit comparing the 
full model with and without the interaction terms. ROC curves were graphed to check the ability 
of the two logistic regression models to predict the probability of depression and anxiety. 
 
3.4 Results 
 
3.4.1 Descriptive statistics 
 
Of the 43,780 post-secondary students, 14.7% were diagnosed or treated by a medical 
professional for depression and 18.4% for anxiety within the past 12-months. Among substance 
use, alcohol (69.3%), cannabis (17.9%), and tobacco use (11%) were most common in the past 
30-days. The majority of participants were female (67.9%), white (70.7%), ages 18-20 years old 
(40.3%), single (83%), undergraduate students (83.2%), domestic (90.6%), living off-campus 
(53.3%), studying full-time (93.3%), and with a GPA of B (45.1%). Table 3.1 provides detailed 
descriptive statistics of the study population. 
 
3.4.2 Univariate analysis  
 
Participants reporting current (past 30-day) alcohol use were 1.74 (95% CI: 1.60-1.90) times 
more likely than those who never used alcohol to report depression. Participants reporting 
current cannabis use were 2.23 (95% CI: 2.08-2.38) times more likely than those who never used 
cannabis to report depression. Individuals reporting current tobacco use were 2.49 (95% CI: 
2.31-2.68) times more likely than those who never used tobacco to report depression. Table 3.2 
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presents the univariate analysis examining depression and substance use variables, and other risk 
factors. 
 
When examining the unconditional association between substance use and anxiety, participants 
who were current alcohol users were 1.92 (95% CI: 1.77-2.08) times more likely to report 
anxiety compared to those who never used alcohol. Participants who were current cannabis users 
were 2.00 (95% CI: 1.88-2.13) times more likely to report anxiety compared to those who never 
used cannabis. Finally, participants who were current tobacco users were 2.04 (95% CI: 1.90-
2.19) times more likely than those who never used tobacco to report anxiety. Table 3.3 
summarizes the univariate analysis examining anxiety and substance use variables, and other risk 
factors. 
 
3.4.3 Multivariate analysis  
 
Two multivariate logistic regression models were built for the two outcomes of interest 
(depression and anxiety). 
 
Model 1: depression and substance use 
 
Findings of our model for depression showed that the odds of having depression were greater for 
current tobacco users (OR=1.36, 95% CI: 1.22-1.52) and to a lesser extent former tobacco users 
(OR=1.20, 95% CI: 1.09-1.33) compared to never tobacco users. An interaction effect was 
observed between cannabis use and other mental health disorders. Current cannabis users with 
(OR=1.17, 95% CI: 1.05-1.31) or without (OR=1.29, 95% CI: 1.05-1.57) other mental health 
disorders were more likely to have depression compared to never cannabis users. Former 
cannabis users without other mental health disorders were more likely to have depression 
(OR=1.38, 95% CI: 1.16-1.65) compared to never cannabis users.  
 
The odds of having depression were increased for current users of other substances (OR=1.37, 
95% CI: 1.21-1.55) and former users of other substances (OR=1.23, 95% CI: 1.10-1.36) 
compared to never users of other substances; females (OR=1.39, 95% CI: 1.28-1.51) and non-
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binary (OR=2.10, 95% CI: 1.75-2.52) gendered individuals compared to males; participants ages 
24 years old and older compared to those ages 18-20 years old (OR=1.21, 95% CI:1.09-1.34); 
divorced students compared to single students (OR=1.58, 95% CI: 1.22-2.04); part-time 
compared to full-time students (OR=1.34, 95% CI: 1.17-1.54); undergraduate compared to 
graduate students (OR=1.19, 95% CI: 1.06-1.35); and individuals reporting a GPA of D or F 
compared to those with a GPA of A (OR=1.79, 95% CI: 1.39-2.31). The following variables 
were excluded from the final model: alcohol use, ethnicity, housing, and being an international 
student (Table 3.4). 
 
Model 2: anxiety and substance  
 
There was an interaction in the final model between alcohol use and gender. The odds of having 
anxiety were 41% greater for female current alcohol users (OR=1.41, 95% CI: 1.24-1.62) and 
43% for female former alcohol users (OR=1.43, 95% CI: 1.22-1.68) compared to female non-
alcohol users. The odds of having been diagnosed with anxiety was increased for current users of 
other substances (OR=1.28, 95% CI: 1.14-1.45) compared to never users of other substances; 
students ages 21-23 years old compared to those ages 18-20 years old (OR=1.18, 95% CI: 1.08-
1.28); and for those with other mental health disorders (OR=50.77, 95% CI: 47.10-54.72) 
compared to those without other mental health disorders. 
 
The odds of having been diagnosed with anxiety were decreased among Black (OR=0.59, 95% 
CI: 0.46-0.75) and Asian or Pacific Islander (OR=0.59, 95% CI: 0.52-0.67) students compared to 
White students. Married students were 14% less likely (OR=0.86, 95% CI: 0.77-0.96) to have an 
anxiety disorder compared to single students. The following variables were excluded from the 
final model: tobacco use, cannabis use, housing status, and study status (Table 3.5).  
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3.5 Discussion  
 
Our study is among the first to examine the association between mental health disorders and 
substance use among post-secondary students in Canada. Specifically, we found a higher rate of 
depression and anxiety (14.7% and 18.4%) in 2016 compared to data from 2013 (10.0 and12.3%) 
among post-secondary students) (17). Similarly, increasing trends were observed with alcohol 
(83.6% in 2013 to 84.4% in 2016) and cannabis use (39.9% in 2013 to 41.6% in 2016) (17). 
Encouragingly, there was a decrease in tobacco use (29.2% in 2013 to 26.9% in 2016) (17).  
Overall, substance use remains a serious public health concern and is highly prevalent among 
Canadian post-secondary students.  
 
There was an initial statistically significant association between depression and alcohol use in 
our univariate analysis. However, in our final model, depression was not significantly associated 
with alcohol use. This provides evidence in support of previous studies, which did not find an 
association between depression and alcohol use among post-secondary students (16, 18). 
However, other studies contradict our finding but were mainly focused in scope to the adolescent 
student population (19, 20). Age may play a critical role in this association as the harmful effects 
of alcohol use and/or depression may differentially impact adolescents (i.e., high school 
students) compared to young adults (post-secondary students) (21, 22). Evidence suggests that 
underage alcohol use is associated with neurodegeneration, changes in functional brain activity, 
and neurocognitive impairments leading to the development of mental health disorders such as 
depression (21). There is also a social context to the patterns of alcohol use. Among young 
adults, alcohol is oftentimes a social behavior, whereas, for adolescents, it may be used as a 
means of coping with underlying problems such as depression or anxiety (22).  
 
Depression was associated with an interaction between cannabis use and other mental health 
disorders. Previous studies found a significant association between depression and cannabis use 
but without an interaction (18, 23). This could be due to a variety of reasons including the 
composition of the study population, cultural and geographical disparities, and differences in key 
characteristics among the various studies. The association between depression and cannabis use 
could be attributed to either direct and/or indirect factors. Direct factors linking depression and 
cannabis use include having a genetic predisposition to both conditions and biological 
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mechanisms altering neurochemical activities in the brain (24). However, another explanation is 
that an individual’s maladaptive cognitive and coping styles (such as own-perception, social 
relationships, and coping with undesirable life events) may lead to occurrence of both depression 
and cannabis use (25).  
 
Our results revealed a significant association between depression and tobacco use. This finding is 
consistent with previous studies that suggest an association exists between depression and 
current smoking among post-secondary students (18, 23). In our study, both current and former 
smokers were more likely to be diagnosed with depression compared to never smokers. 
However, there was no statistically significant difference between current and former smokers. 
This is an important finding as it suggests that former smokers are at similar risk of depression as 
current smokers. There may be a biological explanation for this finding. Smoking initially 
increases the release of dopamine neurotransmitters, which eventually may cause the receptors to 
become insensitive and therefore, over time may require an increased stimulation to have the 
same effect (26). Upon smoking cessation, due to the deprivation of dopamine and the 
occurrence of withdrawal symptoms, the depressive symptoms may develop (26). Thus, 
healthcare providers at post-secondary institutions should be made aware of the risk of 
depression not only among current but also former smokers.  
 
Anxiety was associated with an interaction between alcohol use and gender. Females who used 
alcohol (current and former users) were at an increased risk of self-reported anxiety compared to 
never users. This is in accordance with a previous study found a stronger association between 
anxiety and alcohol use among females (27). Anxiety among male and non-binary participants 
was not associated with alcohol use. These findings highlight the notion that to improve mental 
health disorders and substance use outcomes, interventions should be gender-specific, relatable, 
and account for the different risk profiles among the genders.  
3.6 Strengths and limitations  
 
This study has several strengths. Our dataset was recent and had a large, national sample size. It 
investigated the characteristics and risk factors of two of the most common mental health 
disorders (depression and anxiety). Our population of interest was uniquely focused on post-
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secondary students. Finally, this is one of the few studies examining the association between 
mental health disorders and substance use among post-secondary students in Canada.  
 
The study also has a few limitations. The NCHA-ACHA II, spring 2016 survey is drawn from a 
convenience sample and results may not be entirely generalizable. The survey questions 
regarding mental health disorders and substance use were self-reported, and due to the private 
nature of the questions and possible associated social stigma, there may be some degree of 
underreporting by the participants. However, previous studies have shown that the use of self-
reports for risky health behaviors are accurate and valid (28). Finally, this is a cross-sectional 
study, and we cannot infer causation because temporality is not known.  
 
3.7 Conclusion 
 
This study examined the association between mental health disorders and substance use among 
post-secondary students in Canada. A significant association was found between depression, 
tobacco use and cannabis use and a gender-specific association between anxiety and female 
alcohol users. Interventions that increase awareness and help fight the growing perception of 
substance use as a normalized and accepted behavior among post-secondary students may help to 
alleviate issues related to mental health disorders. Results of this study may help inform student 
health services, university administrators, and healthcare professionals in their efforts to design 
and implement comprehensive educational initiatives, appropriate policies, and effective health 
promotion strategies. 
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Table 3.1: Descriptive statistics 
Variables  Categories Frequency (%) 
Depression  
(missing=539) 
No 36896 85.33 
Yes 6345 14.67 
Anxiety  
(missing=495) 
No 35328 81.62 
Yes 7957 18.38 
Other mental health 
disorders (missing=320) 
No 32812 75.50 
Yes 10648 24.50 
Alcohol use  
(missing=336) 
Never1 6761 15.56 
Former2 6567 15.12 
Current3 30116 69.32 
Cannabis use  
(missing =399) 
Never 25350 58.44 
Former 10261 23.65 
Current 7770 17.91 
Tobacco use  
(missing=306) 
Never 31780 73.10 
Former 6913 15.90 
Current 4781 11.00 
Other substances 
(missing=196) 
Never 35534 81.53 
Former 5292 12.14 
Current 2758 6.33 
Gender  
(missing=558)  
Male 12615 29.19 
Female 29359 67.93 
Non-binary 1248 2.89 
Ethnicity  
(missing=578) 
White 30561 70.74 
Black 1402 3.25 
Hispanic/Latino 888 2.06 
Asian/Pacific Islander 5905 13.67 
Indian 1701 3.94 
Biracial/multiracial 1462 3.38 
Other 1283 2.97 
Age  
(missing=536) 
18-20 17419 40.28 
21-23 13955 32.27 
24 years and older 11870 27.45 
Marital status  
(missing =442) 
Single 35966 82.99 
Married 5498 12.69 
Separated/Divorced 547 1.26 
Others 1327 3.06 
Study status  
(missing=505) 
Undergraduate 36021 83.24 
Graduate 6026 13.92 
Others 1228 2.84 
International student 
(missing=402) 
No 39284 90.56 
Yes 4094 9.44 
Housing 
(missing=398) 
Off-Campus 23141 53.34 
On-Campus 6106 14.07 
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With Parents 14135 32.58 
Enrollment (missing=320) Full-time 40528 93.25 
Part-time 2454 5.65 
Others 478 1.10 
GPA  
(missing=432) 
A 15799 36.45 
B 19562 45.13 
C 6619 15.27 
D/F 626 1.44 
Not Applicable 742 1.71 
1Never users: Never used the substance 
2Former users: Used the substance but not within the past 30-days 
3Current users: Used the substance within the past 30-days  
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Table 3.2: Univariate analysis: Substance use and depression 
Variables  Categories  OR (95% CI) P-
value 
Other mental health disorders 
(Ref=no) 
Yes 45.52 (41.99-49.34) <0.001 
Alcohol use  
(Ref=never1) 
Former2 1.68 (1.51-1.87) <0.001 
Current3 1.74 (1.60-1.90) 
Cannabis use  
(Ref=never) 
Former 1.71 (1.60-1.82) <0.001 
Current 2.23 (2.08-2.38) 
Tobacco use  
(Ref=never) 
Former 1.86 (1.74-1.99) <0.001 
Current 2.49 (2.31-2.68) 
Other substances  
(Ref=never) 
Former 2.16 (2.01-2.32) <0.001 
Current 3.63 (3.33-3.96) 
Gender 
(Ref=male)  
Female 1.79 (1.68-1.92) <0.001 
Non-binary 3.89 (3.40-4.46) 
Age categories  
(Ref=age 18-20) 
21-23 1.10 (1.03-1.17) <0.001 
24 years and older 1.34 (1.26-1.43) 
Ethnicity  
(Ref=white) 
Black 0.58 (0.49-0.70) <0.001 
Hispanic or Latino 0.89 (0.73-1.08) 
Asian or Pacific 
Islander 
0.53 (0.48-0.58) 
Indian 1.56 (1.38-1.75) 
Biracial or 
multiracial 
1.27 (1.11-1.46) 
Other 1.01 (0.86-1.18) 
Marital status 
(Ref=single) 
Married 1.07 (0.99-1.16) <0.001 
Separated/Divorced 2.98 (2.48-3.57) 
others 1.43 (1.24-1.64) 
Housing  
(Ref=on-campus) 
Off-Campus 1.19 (1.10-1.29) <0.001 
With Parents 0.95 (0.87-1.04) 
Enrollment status  
(Ref=full-time) 
Part-time 1.58 (1.43-1.75) <0.001 
Others 1.66 (1.33-2.07) 
Study status  
(Ref=graduate students) 
Undergraduate 
students 
1.29 (1.18-1.40) <0.001 
Others 1.72 (1.47-2.03) 
GPA  
(Ref=A) 
B 1.21 (1.14-1.29) <0.001 
C 1.74 (1.61-1.88) 
D/F 2.48 (2.06-2.98) 
Not Applicable 1.27 (1.03-1.56) 
International student (Ref=no) Yes 0.65 (0.59-0.72) <0.001 
1Never users: Never used the substance 
2Former users: Used the substance but not within the past 30-days 
3Current users: Used the substance within the past 30-days 
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Table 3.3: Univariate analysis: Substance use and anxiety 
Variables  Categories  OR (95% CI) P-
value 
Other mental health 
disorders (Ref=no) 
Yes 54.21 (50.47-58.22) <0.001 
Alcohol use  
(Ref=never1) 
Former2 1.80 (1.63-1.98) <0.001 
Current3 1.92 (1.77-2.08) 
Cannabis use  
(Ref=never) 
Former 1.62 (1.53-1.72) <0.001 
Current 2.00 (1.88-2.13) 
Tobacco use  
(Ref=never) 
Former 1.64 (1.54-1.74) <0.001 
Current 2.04 (1.90-2.19) 
Other substances  
(Ref=never) 
Former 1.90 (1.78-2.03) <0.001 
Current 3.18 (2.93-3.46) 
Gender 
(Ref=male)  
Female 2.29 (2.15-2.44) <0.001 
Non-binary 4.07 (3.57-4.64) 
Age categories  
(Ref=age 18-20) 
21-23 1.16 (1.09-1.22) <0.001 
24 years and older 1.20 (1.13-1.27) 
Ethnicity  
(Ref=white) 
Black 0.42 (0.35-0.51) <0.001 
Hispanic or Latino 0.79(0.66-0.94) 
Asian or Pacific Islander 0.41 (0.37-0.45) 
Indian 1.32 (1.18-1.48) 
Biracial or multiracial 1.23 (1.08-1.39) 
Other 0.94 (0.81-1.08) 
Marital status 
(Ref=single) 
Married 0.99 (0.92-1.07) <0.001 
separated/Divorced 2.49 (2.09-2.98) 
others 1.38 (1.21-1.57) 
Housing  
(Ref=on-campus) 
Off-Campus 1.12 (1.04-1.21) <0.001 
With Parents 0.96 (0.88-1.03) 
Enrollment status  
(Ref=full-time) 
Part-time 1.43 (1.30-1.58) <0.001 
Others 1.54 (1.25-1.90) 
Study status  
(Ref=graduate students) 
Undergraduate students 1.24 (1.15-1.33) <0.001 
Others 1.45 (1.24-1.69) 
GPA  
(Ref=A) 
B 1.10 (1.04-1.16) <0.001 
C 1.42 (1.32-1.52) 
D/F 1.73 (1.44-2.08) 
Not Applicable 1.07 (0.88-1.30) 
International student 
(Ref=no) 
Yes 0.55 (0.50-0.61) <0.001 
1Never users: Never used the substance 
2Former users: Used the substance but not within the past 30-days 
3Current users: Used the substance within the past 30-days 
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Table 3.4: Multivariate analysis: Substance use and depression 
 
Variables  Categories  OR (95% CI) P-value 
Tobacco use 
(Ref=never1) 
Former2 1.20 (1.09-1.33) <0.001 
Current3 1.36 (1.22-1.52) <0.001 
Other substances use 
(Ref=never) 
Former 1.23 (1.10-1.36) <0.001 
Current 1.37 (1.21-1.55) <0.001 
Gender 
(Ref=male)  
Female 1.39 (1.28-1.51) <0.001 
Non-binary 2.10 (1.75-2.52) <0.001 
Age categories  
(Ref=age 18-20) 
21-23 1.00 (0.92-1.09) 0.98 
24 years and older 1.21 (1.09-1.34) 0.003 
Marital status 
(Ref=single) 
Married 0.98 (0.87-1.10) 0.72 
Divorced 1.58 (1.22-2.04) 0.005 
others 1.07 (0.89-1.29) 0.49 
Enrollment status  
(Ref=full-time) 
Part-time 1.34 (1.17-1.54) <0.001 
Others 1.26 (0.93-1.71) 0.13 
Study status  
(Ref=graduate students) 
Undergraduate students 1.19 (1.06-1.35) 0.005 
Others 1.46 (1.17-1.82) <0.001 
GPA  
(Ref=A) 
B 1.13 (1.04-1.23) 0.003 
C 1.53 (1.37-1.70) <0.001 
D/F 1.79 (1.39-2.31) <0.001 
Not Applicable 1.19 (0.91-1.57) 0.21 
 
Variables  Categories  OR (95% CI) 
Other Mental Health Disorders=0 
Cannabis use (Ref=never) Former 1.38 (1.16-1.65) 
Current 1.29 (1.05-1.57) 
Other Mental Health Disorders=1 
Cannabis use (Ref=never) Former 1.06 (0.95-1.17) 
Current 1.17 (1.05-1.31) 
1Never users: Never used the substance 
2Former users: Used the substance but not within the past 30-days 
3Current users: Used the substance within the past 30-days 
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Table 3.5: Multivariate analysis: Substance use and anxiety  
Variables  Categories  OR (95% CI) P-value 
Other substances use  
(Ref=never1) 
Former2 1.09 (0.98-1.20) 0.08 
Current3 1.28 (1.14-1.45) 0.002 
Age categories  
(Ref=age 18-20) 
21-23 1.18 (1.08-1.28) <0.001 
24 years and older 1.01 (0.92-1.11) 0.66 
Ethnicity  
(Ref=white) 
Black 0.59 (0.46-0.75) <0.001 
Hispanic or Latino 0.79 (0.62-1.01) 0.06 
Asian or Pacific 
Islander 
0.59 (0.52-0.67) <0.001 
Indian 0.89 (0.76-1.05) 0.13 
Biracial or multiracial 1.07 (0.90-1.28) 0.51 
Other 0.90 (0.74-1.10) 0.22 
Marital Status 
(Ref=single) 
Married 0.86 (0.77-0.96) 0.01 
Divorced 1.24 (0.95-1.62) 0.09 
others 1.02 (0.84-1.23) 0.82 
Enrollment Status  
(Ref=full-time) 
Part-time 1.23 (1.07-1.42) 0.00 
Others 1.33 (0.97-1.81) 0.07 
GPA  
(Ref=A) 
B 0.91 (0.84-0.99) 0.02 
C 1.06 (0.96-1.18) 0.32 
D/F 0.92 (0.71-1.20) 0.53 
Not Applicable 1.03 (0.78-1.36) 0.94 
International Student (Ref=yes) No 1.32 (1.15-1.53) <0.001 
Other Mental Health Disorders 
(Ref=no) 
Yes 50.77 (47.10-54.72) <0.001 
 
Variables  Categories  OR (95% CI) 
Female 
Alcohol use (Ref=never) Former 1.43 (1.22-1.68) 
Current 1.41 (1.24-1.62) 
Male 
Alcohol use (Ref=never) Former 1.27 (0.97-1.68) 
Current 0.97 (0.78-1.20) 
Non-binary 
Alcohol use (Ref=never) Former 1.56 (0.84-2.89) 
Current 1.65 (0.98-2.76) 
1Never users: Never used the substance 
2Former users: Used the substance but not within the past 30-days 
3Current users: Used the substance within the past 30-days 
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Chapter 4: Conclusion 
 
4.1 Overview  
 
Mental health disorders and substance use pose a major public health concern. These two 
conditions contribute a significant portion of world’s disease burden measured by disability-
adjusted life years (1). The majority of mental health disorders and substance use behaviors, 
often times, emerge during adolescence and young adulthood (2). Early onset of co-occurrence 
may disrupt the course of cognitive and emotional development and may negatively impact an 
individual’s life and well-being (i.e., education, work, relationships, health, and safety). Due to 
the lack of appropriate and integrated healthcare services for co-occurring disorders, affected 
individuals are more likely to experience negative outcomes and become high-end users of 
healthcare resources (3). Thus, investigative efforts (including the present thesis) in this 
important topic are needed.  
 
4.2 First study (Chapter 2): Purpose, key findings, recommendations, and future research  
 
4.2.1 Purpose 
 
The purpose of the first study was to determine and quantify the association and directionality 
between mental health disorders (depression and anxiety) and substance use (alcohol, cannabis, 
and tobacco) among adolescents and/or young adults by conducting a systematic review and 
meta-analysis. This is an important and growing public health concern that has been widely 
published in the literature. However, to date, our understanding is limited and the reported 
findings, at times have been conflicting. To address this issue, a systematic review (the collection 
and synthesis of all relevant and empirical evidence) and meta-analysis (statistical analysis 
summary) was conducted. Our study supports the premise that evidence-based, decision-making 
is integral for the development, evaluation and implementation of interventions that address 
mental health disorders and substance use among adolescents and young adults. 
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4.2.2 Key findings 
 
Our systematic review and meta-analysis, included 36 (19 cross-sectional and 17 longitudinal) 
studies. We found a significant positive association between: 1) depression and alcohol use 
(OR=1.50, 95% CI: 1.24-1.83); 2) depression and cannabis use (OR=1.29, 95% CI: 1.10-1.51); 
3) depression and tobacco use (OR=1.65, 95% CI: 1.43-1.92); 4) anxiety and alcohol use 
(OR=1.54, 95% CI: 1.19-2.00); 5) anxiety and cannabis use (OR=1.36, 95% CI: 1.02-1.81), and 
6) anxiety and tobacco use (OR=2.21, 95% CI: 1.54-3.17).  
 
Further analysis showed a significant positive bidirectional association between tobacco use at 
baseline leading to depression at follow-up (OR=1.87, CI=1.23-2.85) and depression at baseline 
which lead to tobacco use later in life (OR=1.22, CI=1.09-1.37). Additionally, we found a 
significant unidirectional relationship between cannabis use at baseline leading to depression at 
follow-up (OR=1.33, CI=1.19-1.49). 
 
4.2.3 Recommendations 
 
In our study, the co-occurrence of mental health disorders and substance use among adolescents 
and young adults was significant, and the following recommendations are provided based on our 
findings. 
 
1) Bilateral cooperation between two nations (U.S. and Canada)  
This systematic review focused on mental health disorders and substance use in the U.S. and 
Canada. These two countries share many common socio-cultural factors, demonstrate similar 
patterns in the prevalence of mental health disorders and substance use, and report common 
health priorities (i.e., advancement of mental health and substance use services). However, 
despite their many similarities, they also present distinct differences. For instance, Canadian 
students reported a lower prevalence of depression and anxiety, while U.S. students had a lower 
prevalence of substance use (4, 5). Interestingly, a higher proportion of Canadian students 
reported receiving health-related information about depression and anxiety, while a higher 
proportion of U.S. students received information about substance use (4, 5). These findings may 
suggest that awareness campaigns were more effective for mental health disorders in Canada, 
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and substance use in the U.S. Therefore, it would be advisable for key stakeholders at 
educational settings in both the U.S. and Canada to collaborate and exchange information and 
ideas on how to further improve their health education and promotion programs. Establishing 
binational partnerships and cooperation may produce best practice guidelines and effective 
strategies and interventions for mental health disorders and substance use across campuses in 
both the U.S. and Canada. 
 
2) Implementation of the quadrants of care model (The New York Model) 
In our systematic review, we found significant associations between 1) depression/anxiety 
symptoms and low intensity of substance use; 2) depression/anxiety symptoms and high intensity 
of substance use; 3) depression/anxiety disorders and low intensity of substance use; and 4) 
depression/anxiety disorders and high intensity of substance use. It became apparent that as the 
severity of mental health disorders and the intensity of substance use varied, different approaches 
to their healthcare management were needed. Thus, we propose using the quadrants of care 
model (6), to most appropriately direct the management efforts of the healthcare professional in 
addressing these two conditions (Table 4.1).  
- Depression/anxiety symptoms and low intensity of substance use: individuals treated at 
primary care settings or referred to other providers with minimal follow-up. 
- Depression/anxiety symptoms and high intensity of substance use or depression/anxiety 
disorders and low intensity of substance use: individuals treated collaboratively by two or 
more service providers by using referrals with each provider in charge of treating a specific 
condition.   
- Depression/anxiety disorders and high intensity of substance use: individuals treated 
simultaneously by two or more expert service providers at one point of access to deliver an 
integrated treatment plan for both conditions.    
By following this model, individuals will receive an appropriate level of care based on their 
needs, and this will ensure efficient use of available resources. 
 
3) Reforming the healthcare system  
To address the growing prevalence of co-occurrence of disease (including mental health 
disorders and substance use), it is recommended that serious consideration is given to reforming 
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the healthcare system. Healthcare reforms are needed to make necessary changes from the 
current parallel and independent practice sectors towards coordinated systems of care. To 
improve efficiency, coordinated practice sectors will require shared funding, developing 
mandates in concert, and treating affected individuals collaboratively. Reforms should be broad 
and encompassing all levels of service delivery including health promotion and prevention, 
diagnosis, treatment, and research. 
 
4) Efficient use of limited resources 
Preventive interventions, early detection, diagnosis, and treatment of the co-occurrence of mental 
health disorders and substance use, can improve the quality of life of adolescents and young 
adults. Addressing this issue upstream will reduce the associated healthcare costs and permit the 
efficient use of limited resources, including the need for frequent psychiatric hospitalizations, 
over-use of emergency departments, and ambulatory care.  
 
4.2.4 Future research 
 
The following three ideas are presented as possible future studies in the examination of mental 
health disorders and substance use.  
1) To examine best practices in the prevention, diagnosis, treatment, and recurrence of mental 
health disorders and substance use.  
2) To determine whether substance use cessation leads to remission of depression or anxiety or 
treatment of depression or anxiety leads to substance use cessation. 
3) To use standardized definitions and categorizations of mental health disorders and substance 
use along with highly reliable and validated survey instruments to improve comparability 
between studies.  
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4.3 Second study (Chapter 3): Purpose, key findings, recommendations, and future 
research 
 
4.3.1 Purpose 
 
The purpose of the second study was to determine the prevalence and association between 
mental health disorders (depression and anxiety) and substance use (alcohol, cannabis, and 
tobacco) among students attending Canadian post-secondary institutions. Despite the high 
prevalence of mental health disorders and substance use among post-secondary students, little is 
known about the independent association between these two conditions in Canada. To address 
this issue, secondary data analysis was conducted. Descriptive statistics of the study population 
were provided, and multivariate logistic regression models were used to estimate the association 
between the dependent variables (depression and anxiety) and the independent variables 
(alcohol, cannabis, and tobacco). 
 
4.3.2 Key findings 
 
Our secondary data analysis was based on the spring 2016 ACHA-NCHA II - Canadian 
Reference Group survey. Our study found that 14.7% of post-secondary students were diagnosed 
or treated for depression and 18.4% for anxiety within the past 12-months. 
 
Further analysis showed that the odds of having depression were greater for current tobacco 
users (OR=1.36, 95% CI: 1.22-1.52) and former tobacco users (OR=1.20, 95% CI: 1.09-1.33). 
Current cannabis users with (OR=1.17, 95% CI: 1.05-1.31) or without (OR=1.29, 95% CI: 1.05-
1.57) other mental health disorders were more likely to have depression. Also, former cannabis 
users without other mental health disorders were more likely to have depression (OR=1.38, 95% 
CI: 1.16-1.65). The odds of having anxiety were greater for current (OR=1.41, 95% CI: 1.24-
1.62) and former (OR=1.43, 95% CI: 1.22-1.68) female alcohol users.  
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4.3.3 Recommendations  
 
In our study, the co-occurrence of mental health disorders and substance use among Canadian 
post-secondary students was significant, and the following recommendations are provided based 
on our findings. 
 
1) Integrated holistic approach 
Mental health disorders and substance use are priority issues in Canada. Therefore, developing a 
holistic and integrative approach to address these two conditions is critical. Effective leadership 
and collaborative efforts among key stakeholders (including federal and provincial 
governments), providers (including community and school-based settings, mental health and 
substance use clinicians, psychiatrists, and psychologists), and families (living with affected or at 
risk individuals) are essential to improve healthcare outcomes. Additional improvements to the 
medical referral system, expanding the scope of provincial healthcare coverage and evaluating 
existing workforce capacity, training, and flows are paramount.  
 
2) Gender-specific programs 
This study found a gender-specific association between mental health disorders (anxiety) and 
substance use (alcohol) among females. To improve mental health disorders and substance use 
outcomes, interventions should be gender-specific, relatable, and account for the different risk 
profiles among the genders.  
 
3) Smoke free campuses  
Our study found significant associations and directionality between mental health disorders 
(depression) and substance use (cannabis and tobacco). Therefore, we strongly support moving 
to smoke-free campuses. Policies that support smoke free campuses not only provide protection 
from second-hand smoke, but will help discourage cannabis and tobacco use among post-
secondary students.  
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4) Awareness programs  
There are several national awareness campaigns in Canada, addressing the stigma associated 
with mental health disorders (such as Bell “let’s talk” campaign) (7, 8). However, there is a need 
for awareness campaigns that acknowledge a link between mental health disorders and/or 
substance use problems. Such collaborative campaigns may prove beneficial by increasing social 
supports, reducing barriers in accessing treatment services and decreasing social stigma and 
discrimination.  
 
5) Training of healthcare providers 
It is essential to cross-train healthcare providers from different sectors to increase their 
awareness of the existing association between mental health disorders and substance use (current 
and former). There is a need for the characterization of patient risk profiles, the use of valid 
assessment tools, and updated diagnostic and treatment guidelines to help improve outcomes for 
these two conditions among adolescents and young adults. 
 
4.3.4 Future research 
 
The following four ideas are presented as possible future studies in the examination of mental 
health disorders and substance use.  
1) To determine the extent of the severity of depression or anxiety associated with the pattern, 
intensity, and quantity of substance use. 
2) To examine documented diagnoses of depression or anxiety from medical records with 
biologically quantifiable substance use. 
3) To assess the sequence of events, relatedness, and temporality between mental health 
disorders and substance use by conducting longitudinal studies. 
4) To determine whether the risk of mental health disorders among former substance users 
decreases over time.  
 
4.4 Conclusion 
 
Mental health disorders and substance use are interlinked and represent a serious threat to the 
health and well-being of adolescents and young adults. The co-occurrence of these two 
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conditions presents complex challenges in their prevention, diagnosis, and treatment. If left 
untreated, these conditions may result in loss of productivity, poor educational outcomes, 
increased psychiatric hospitalizations/emergency department visits, inefficient use of limited 
healthcare resources, and a higher prevalence of chronic diseases. By affecting change at the 
personal (increase awareness), interpersonal (decrease stigma), and societal (policies and 
interventions) levels, we can assist adolescents and young adults to make better choices, seek 
supports as needed, and live healthier and well-adjusted lives.  
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Table 4.1: Quadrants of care model 
 
 Intensity of substance use 
Low High 
S
ev
er
it
y
 o
f 
d
ep
r
es
si
o
n
/a
n
x
ie
ty
 
S
y
m
p
to
m
s 
Individuals treated at primary care 
settings or referred to other providers 
with minimal follow-up 
Individuals treated collaboratively by 
two or more service providers by using 
referrals with each provider in charge of 
treating a specific condition 
D
is
o
rd
er
s 
Individuals treated collaboratively by 
two or more service providers by 
using referrals with each provider in 
charge of treating a specific condition 
Individuals treated simultaneously by 
two or more expert service providers at 
one point of access to deliver an 
integrated treatment plan for both 
conditions 
 
 
